Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
results | items | results | results | items | results | ||
2023 | 2023 | 2023 | 2022 | 2022 | 2022 | ||
Notes | £m | £m | £m | £m | £m | £m | |
Continuing operations | |||||||
Revenue | 4 | ||||||
Net operating expenses | 6 | ( | ( | ( | ( | ( | ( |
Other operating income | 6 | ||||||
Operating profit/(loss) before joint | |||||||
ventures and associates | ( | ( | |||||
Share of results of joint ventures | |||||||
and associates | 19 | ( | ( | ||||
Operating profit/(loss) | ( | ( | |||||
Fair value gain/(loss) on investments | 19 | ( | ( | ||||
Profit on disposal of subsidiaries | |||||||
and operations | |||||||
Distributions received from investments | 19 | ||||||
Finance income | 10 | ||||||
Finance costs | 11 | ( | ( | ( | ( | ( | ( |
Profit/(loss) before tax | ( | ( | |||||
Tax (charge)/credit | 12 | ( | ( | ( | ( | ||
Profit/(loss) for the year from continuing operations | ( | ( | |||||
Discontinued operations | |||||||
Profit for the year from discontinued operations | |||||||
Profit/(loss) for the year | ( | ||||||
Attributable to: | |||||||
– Equity holders of the Company | 14 | ( | |||||
– Non-controlling interests | 36 | ( | |||||
Earnings per share | |||||||
From continuing operations | |||||||
– Basic (p) | 14 | ||||||
– Diluted (p) | 14 | ||||||
From continuing and discontinued | |||||||
operations | |||||||
– Basic (p) | 14 | ||||||
– Diluted (p) | 14 |
2023 | 2022 | ||
Notes | £m | £m | |
Profit for the year | |||
Items that will not be reclassified subsequently to profit or loss: | |||
Remeasurement of the net retirement benefit pension obligation | 33 | ( | |
Tax credit relating to items that will not be reclassified to profit or loss | |||
Total items that will not be reclassified subsequently to profit or loss | ( | ||
Items that may be reclassified subsequently to profit or loss: | |||
Exchange (loss)/gain on translation of foreign operations | ( | ||
Exchange loss arising on disposal of foreign operations | ( | ||
Net investment hedges: | |||
Exchange gain/(loss) on net investment hedge | ( | ||
Gain on derivatives in net investment hedging relationships | |||
Cash flow hedges: | |||
Fair value (loss)/gain arising on hedging instruments | ( | ||
Less: gain/(loss) reclassified to profit or loss | ( | ||
Movement in cost of hedging reserve | ( | ||
Tax charge relating to items that may be reclassified subsequently to profit or loss | ( | ( | |
Total items that may be reclassified subsequently to profit or loss | ( | ||
Other comprehensive (expense)/income for the year | ( | ||
Total comprehensive income for the year | |||
Total comprehensive income attributable to: | |||
– Equity holders of the Company | |||
– Non-controlling interests | |||
Total comprehensive income for the year attributable to equity holders of the Company: | |||
– Continuing operations | |||
– Discontinued operations | |||
Share | Non- | |||||||
premium | Translation | Other | Retained | controlling | ||||
Share capital | account | reserve | reserves | earnings | Total | interests | Total equity | |
£m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2022 | ( | |||||||
Profit for the year | ||||||||
Exchange gain on translation of foreign | ||||||||
operations | ||||||||
Exchange loss on net | ||||||||
investment hedge | ( | ( | ( | |||||
Gain arising on derivative hedges | ( | |||||||
Foreign exchange recycling | ||||||||
of disposed entities | ( | ( | ( | |||||
Actuarial gain on defined | ||||||||
benefit pension schemes | ||||||||
Tax relating to components | ||||||||
of other comprehensive income | ( | ( | ( | |||||
Total comprehensive income for the year | ( | |||||||
Dividends to shareholders | ( | ( | ( | |||||
Dividends to non-controlling interests | ( | ( | ||||||
Share award expense | ||||||||
Shares for Trust purchase | ( | ( | ( | |||||
Transfer of vested LTIPs | ( | |||||||
Share buyback | ( | ( | ( | ( | ( | |||
Acquisition of non-controlling interests | ||||||||
At 31 December 2022 | ||||||||
Profit for the year | ||||||||
Exchange loss on translation of foreign | ||||||||
operations | ( | ( | ( | ( | ||||
Exchange gain on net | ||||||||
investment hedge debt | ||||||||
Gain/(loss) arising on derivative hedges | ( | |||||||
Actuarial gain on defined | ||||||||
benefit pension schemes | ( | ( | ( | |||||
Tax relating to components | ||||||||
of other comprehensive income | ( | ( | ( | |||||
Total comprehensive income for the year | ( | ( | ||||||
Dividends to shareholders | ( | ( | ( | |||||
Dividends to non-controlling interests | ( | ( | ||||||
Share award expense | ||||||||
Issue of share capital | ||||||||
Shares for Trust purchase | ( | ( | ( | |||||
Transfer of vested LTIPs | ( | |||||||
Share buyback | ( | ( | ( | ( | ( | |||
Acquisition of non-controlling interests | ||||||||
Transactions with non-controlling interests | ( | ( | ( | |||||
Remeasurement of put call options | ||||||||
At 31 December 2023 | ( |
At | At | ||
31 December | 31 December | ||
2023 | 2022 | ||
Notes | £m | £m | |
Non-current assets | |||
Goodwill | 15 | ||
Other intangible assets | 16 | ||
Property and equipment | 18 | ||
Right-of-use assets | 37 | ||
Investments in joint ventures and associates | 19 | ||
Other investments | 19 | ||
Deferred tax assets | 20 | ||
Retirement benefit surplus | 33 | ||
Finance lease receivables | 37 | ||
Other receivables | 21 | ||
Derivative financial instruments | 22 | ||
Current assets | |||
Inventory | 23 | ||
Trade and other receivables | 21 | ||
Current tax asset | 12 | ||
Cash and cash equivalents | 26 | ||
Finance lease receivables | 37 | ||
Derivative financial instruments | 22 | ||
Total assets | |||
Current liabilities | |||
Borrowings | 27 | ( | |
Lease liabilities | 37 | ( | ( |
Derivative financial instruments | 22 | ( | |
Current tax liabilities | 12 | ( | ( |
Provisions | 28 | ( | ( |
Contingent consideration and put call options | 29 | ( | ( |
Trade and other payables | 30 | ( | ( |
Deferred income | 30 | ( | ( |
( | ( | ||
Non-current liabilities | |||
Borrowings | 27 | ( | ( |
Lease liabilities | 37 | ( | ( |
Derivative financial instruments | 22 | ( | ( |
Deferred tax liabilities | 20 | ( | ( |
Retirement benefit obligation | 33 | ( | ( |
Provisions | 28 | ( | ( |
Contingent consideration and put call options | 29 | ( | ( |
Trade and other payables | 30 | ( | ( |
Deferred income | 30 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | |||
Share capital | 34 | ||
Share premium | 34 | ||
Translation reserve | ( | ||
Other reserves | 35 | ||
Retained earnings | |||
Equity attributable to equity holders of the parent | |||
Non-controlling interest | 36 | ||
Total equity |
2023 | 2022 | ||
Notes | £m | £m | |
Operating activities | |||
Cash generated by continuing operations | 32 | ||
Income taxes paid | ( | ( | |
Interest paid | ( | ( | |
Net cash inflow from operating activities – continuing operations | |||
Net cash inflow from operating activities – discontinued operations | |||
Net cash inflow from operating activities | |||
Investing activities | |||
Interest received | |||
Dividends received from investments | 19 | ||
Distributions received from investments | 19 | ||
Purchase of property and equipment | 18 | ( | ( |
Purchase of intangible software assets | 16 | ( | ( |
Product development costs additions | 16 | ( | ( |
Purchase of intangibles related to titles, brands and customer relationships | 16 | ( | ( |
Acquisition of subsidiaries and operations, net of cash acquired | 17 | ( | ( |
Acquisition of investments | 19 | ( | |
Acquisition of convertible bonds | 19 | ( | |
Cash outflow from disposal of subsidiaries and operations | ( | ( | |
Net cash outflow from investing activities – continuing operations | ( | ( | |
Net cash inflow from investing activities – discontinued operations | |||
Net cash (outflow)/inflow from investing activities | ( | ||
Financing activities | |||
Dividends paid to shareholders | 13 | ( | ( |
Dividends paid to non-controlling interests | 13 | ( | ( |
Repayment of loans | 25 | ( | ( |
Repayment of borrowings acquired | 17 | ( | ( |
Borrowing fees paid | ( | ||
Repayment of principal lease liabilities | 37 | ( | ( |
Finance lease receipts | 37 | ||
Settlement of derivative liability associated with borrowings | ( | ||
Acquisition of non-controlling interests | ( | ||
Cash outflow from share buyback | 34 | ( | ( |
Cash outflow from purchase of shares for Trust | 35 | ( | ( |
Net cash outflow from financing activities – continuing operations | ( | ( | |
Net cash (outflow)/inflow from financing activities – discontinued operations | |||
Net cash outflow from financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | ( | ||
Effect of foreign exchange rate changes | ( | ||
Cash and cash equivalents at beginning of the year | 26 | ||
Cash and cash equivalents at end of the year | 26 |
Revenue type | Performance obligations | Revenue recognition accounting policy | Timing of customer payments |
Exhibitor | Provision of services | Performance obligations are satisfied at the point of | Payments for events are normally received |
and related | associated with exhibition | time that services are provided to the customer with | in advance of the event dates, which are |
services | and conference events, | revenue recognised when the event has taken place. | typically up to 12 months in advance of the |
including virtual events. | event date, and are held as deferred income | ||
until the event date. | |||
Subscriptions | Provision of journals and | Performance obligations are satisfied both at a point | Subscription payments are normally |
online information services | in time, with revenue recognised at that point and | received in advance of the commencement | |
that are provided on a | over time, with revenue recognised straight line over | of the subscription period, which is typically | |
periodic basis or updated on | the period of the subscription. | a 12-month period, and are held as deferred | |
a real-time basis. | income. | ||
Transactional | Provision of books and | Revenue is recognised at the point of time when | Transactional sales to customers are |
sales | specific publications in | control of the product is passed to the customer or | typically on credit terms and customers pay |
print or digital format. | the information service has been provided. Control is | according to these terms. | |
passed to the customer when the goods have been | |||
delivered to them. | |||
Attendee | Provision of exhibition or | Performance obligations are satisfied at the point of | Payments by attendees are normally |
revenue | conference events. | time that the event is held, with attendee revenue | received either in advance of the event date |
recognised at this date. | and are held as deferred income until the | ||
event date, or at the event. | |||
Marketing and | Provision of advertising and | Performance obligations are satisfied over the period | Payment for such services are normally |
advertising | marketing services. | of the advertising subscription or over the period | received in advance of the marketing |
services | when the marketing services are provided. Revenue is | or advertising period and are held | |
recognised on a straight-line basis over the | as deferred income until the services | ||
subscription period. | are provided. | ||
Sponsorship | Provision of event | Revenue relating to sponsorship at events | Payments for such services are normally |
revenue | sponsorship. | is recognised on a point of time basis at the | received in advance of the sponsorship |
event date. | period and are held as deferred income | ||
until the services are provided. |
Informa | Informa | Informa | Taylor & | ||
Markets | Tech | Connect | Francis | Total | |
£m | £m | £m | £m | £m | |
Continuing operations | |||||
Exhibitor | 1,309.4 | 85.1 | 103.8 | – | 1,498.3 |
Subscriptions | 34.8 | 58.7 | 144.0 | 346.1 | 583.6 |
Transactional sales | 4.3 | 26.5 | 45.6 | 272.0 | 348.4 |
Attendee | 74.8 | 54.4 | 164.8 | – | 294.0 |
Marketing and advertising services | 91.0 | 116.3 | 36.0 | 0.9 | 244.2 |
Sponsorship | 79.0 | 55.7 | 86.4 | – | 221.1 |
Total | 1,593.3 | 396.7 | 580.6 | 619.0 | 3,189.6 |
Informa | Informa | Informa | Taylor & | ||
Markets | Tech | Connect | Francis | Total | |
£m | £m | £m | £m | £m | |
Continuing operations | |||||
Exhibitor | 708.7 | 63.5 | 48.0 | – | 820.2 |
Subscriptions | 27.7 | 57.2 | 121.9 | 325.9 | 532.7 |
Transactional sales | 5.4 | 27.5 | 37.8 | 266.8 | 337.5 |
Attendee | 55.4 | 51.5 | 114.4 | – | 221.3 |
Marketing and advertising services | 74.4 | 85.2 | 23.6 | 0.9 | 184.1 |
Sponsorship | 61.7 | 35.9 | 69.0 | – | 166.6 |
Total | 933.3 | 320.8 | 414.7 | 593.6 | 2,262.4 |
Informa | Informa | Informa | Taylor & | ||
Markets | Tech | Connect | Francis | Total | |
£m | £m | £m | £m | £m | |
Revenue | 1,593.3 | 396.7 | 580.6 | 619.0 | 3,189.6 |
Adjusted operating profit before joint ventures and associates | 454.7 | 72.9 | 102.5 | 217.9 | 848.0 |
Share of adjusted results of joint ventures and associates | 5.8 | – | – | – | 5.8 |
Adjusted operating profit | 460.5 | 72.9 | 102.5 | 217.9 | 853.8 |
Intangible asset amortisation (Note 16) | (179.0) | (37.5) | (43.4) | (52.9) | (312.8) |
Impairment – acquisition-related and other intangibles | (24.5) | (0.3) | (0.3) | – | (25.1) |
Reversal of impairment/(impairment) – IFRS 16 right-of-use assets | 0.1 | (0.3) | 0.8 | – | 0.6 |
Acquisition costs (Note 7) | (15.7) | (17.0) | (19.7) | (0.9) | (53.3) |
Integration costs (Note 7) | (8.3) | (2.9) | (8.5) | – | (19.7) |
Restructuring and reorganisation costs (Note 7) | 1.8 | 1.1 | (0.5) | (13.4) | (11.0) |
Fair value (loss)/gain on contingent consideration (Note 7) | (7.3) | 82.4 | 0.7 | (0.2) | 75.6 |
Foreign exchange loss on swap settlement | (2.8) | (0.7) | (1.0) | (1.1) | (5.6) |
Credit in respect of unallocated cash | 3.3 | 0.8 | 1.2 | – | 5.3 |
Operating profit | 228.1 | 98.5 | 31.8 | 149.4 | 507.8 |
Fair value gain on investments | 1.3 | ||||
Profit on disposal of subsidiaries and operations (Note 19) | 3.0 | ||||
Finance income (Note 10) | 47.4 | ||||
Finance costs (Note 11) | (67.4) | ||||
Profit before tax | 492.1 |
Informa | Informa | Informa | Taylor & | ||
Markets | Tech | Connect | Francis | Total | |
£m | £m | £m | £m | £m | |
Revenue | 933.3 | 320.8 | 414.7 | 593.6 | 2,262.4 |
Adjusted operating profit before joint ventures and associates | 172.7 | 55.5 | 57.2 | 208.8 | 494.2 |
Share of adjusted results of joint ventures and associates | 2.1 | – | – | – | 2.1 |
Adjusted operating profit | 174.8 | 55.5 | 57.2 | 208.8 | 496.3 |
Intangible asset amortisation (Note 16) | (168.6) | (27.0) | (26.8) | (52.9) | (275.3) |
Impairment – acquisition-related and other intangibles | (6.7) | – | (0.2) | – | (6.9) |
Reversal of impairment/(impairment) – IFRS 16 right-of-use assets | 2.6 | 0.1 | (3.8) | 1.2 | 0.1 |
Reversal of impairment/(impairment) – property and equipment | 0.4 | 0.1 | (0.1) | 0.3 | 0.7 |
Acquisition costs (Note 7) | (0.1) | (11.1) | (0.3) | (0.3) | (11.8) |
Integration costs (Note 7) | (0.3) | (1.7) | (8.4) | 0.2 | (10.2) |
Restructuring and reorganisation costs (Note 7) | 2.0 | 0.7 | (2.4) | 1.3 | 1.6 |
Onerous contracts associated with COVID-19 (Note 7) | (5.0) | 0.5 | (0.2) | – | (4.7) |
Fair value loss on contingent consideration (Note 7) | (0.1) | (3.7) | – | (1.9) | (5.7) |
Operating (loss)/profit | (1.0) | 13.4 | 15.0 | 156.7 | 184.1 |
Fair value loss on investments | (0.9) | ||||
Profit on disposal of subsidiaries and operations | 11.6 | ||||
Distributions received from investments | 20.6 | ||||
Finance income (Note 10) | 27.5 | ||||
Finance costs (Note 11) | (74.1) | ||||
Profit before tax | 168.8 |
31 December | 31 December | |
2023 | 2022 | |
£m | £m | |
Informa Markets | 6,838.7 | 6,306.0 |
Informa Connect | 1,632.1 | 998.3 |
Informa Tech | 1,368.2 | 1,419.6 |
Taylor & Francis | 968.5 | 959.0 |
Total segment assets | 10,807.5 | 9,682.9 |
Unallocated assets | 716.7 | 2,462.8 |
Total assets | 11,524.2 | 12,145.7 |
Revenue | Segment non-current assets | |||
2023 | 2022 | 2023 | 2022 | |
£m | £m | £m | £m | |
UK | 188.8 | 127.8 | 2,278.3 | 1,826.4 |
Continental Europe | 355.1 | 304.9 | 945.0 | 950.4 |
North America | 1,541.4 | 1,267.4 | 4,927.2 | 4,461.5 |
China | 449.0 | 99.2 | 1,767.4 | 1,818.4 |
Rest of World | 655.3 | 463.1 | 224.3 | 142.5 |
3,189.6 | 2,262.4 | 10,142.2 | 9,199.2 |
Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
results | items | results | results | items | results | ||
2023 | 2023 | 2023 | 2022 | 2022 | 2022 | ||
Notes | £m | £m | £m | £m | £m | £m | |
Cost of sales (excluding staff costs, depreciation and COVID-19 adjusting items) | 1,123.7 | – | 1,123.7 | 778.3 | – | 778.3 | |
Staff costs | 8 | 900.6 | – | 900.6 | 745.8 | – | 745.8 |
Auditor’s remuneration for audit services | 6.3 | – | 6.3 | 3.9 | – | 3.9 | |
Depreciation – property and equipment | 18 | 13.5 | – | 13.5 | 11.7 | – | 11.7 |
Depreciation – IFRS 16 right-of-use assets | 37 | 26.3 | – | 26.3 | 24.8 | – | 24.8 |
Amortisation of other intangible assets | 16 | 41.1 | 312.8 | 353.9 | 35.2 | 275.3 | 310.5 |
Impairment – acquisition-related and other intangibles | 7 | – | 25.1 | 25.1 | – | 6.9 | 6.9 |
Reversal of impairment – IFRS 16 | |||||||
right-of-use assets | 7 | – | (0.6) | (0.6) | – | (0.1) | (0.1) |
Reversal of impairment – property | |||||||
and equipment | 18 | – | – | – | – | (0.7) | (0.7) |
Acquisition costs | 7 | – | 53.3 | 53.3 | – | 11.8 | 11.8 |
Integration costs | 7 | – | 18.2 | 18.2 | – | 10.2 | 10.2 |
Restructuring and reorganisation costs | 7 | – | 11.0 | 11.0 | – | (1.6) | (1.6) |
Onerous contracts associated | |||||||
with COVID-19 | 7 | – | – | – | – | 4.6 | 4.6 |
Fair value gain on contingent consideration | 7 | – | (87.6) | (87.6) | – | – | – |
Fair value loss on contingent consideration | 7 | – | 12.0 | 12.0 | – | 5.7 | 5.7 |
Net foreign exchange loss | 7 | 7.6 | 5.6 | 13.2 | 5.0 | – | 5.0 |
Credit in respect of unallocated cash | 7 | – | (5.3) | (5.3) | – | – | – |
Other operating expenses | 222.5 | – | 222.5 | 163.5 | – | 163.5 | |
Total net operating expenses and other operating income before share of joint | |||||||
ventures and associates | 2,341.6 | 344.5 | 2,686.1 | 1,768.2 | 312.1 | 2,080.3 |
2023 | 2022 | |
£m | £m | |
Fees payable to the Company’s auditor for the audit of the Company’s annual financial statements | 5.0 | 3.2 |
Fees payable to the Company’s auditor and its associates for other services to the Group: | ||
Audit of the Company’s subsidiaries | 1.3 | 0.7 |
Total audit fees | 6.3 | 3.9 |
Fees payable to the Company’s auditor for non-audit services comprises: | ||
Half-year review | 0.3 | 0.2 |
Other services | 0.1 | 0.9 |
Total non-audit fees | 0.4 | 1.1 |
2023 | 2022 | ||
Notes | £m | £m | |
Continuing operations | |||
Intangible asset amortisation | 16 | 312.8 | 275.3 |
Impairment – acquisition-related and other intangible assets | 16 | 25.1 | 6.9 |
Reversal of impairment – IFRS 16 right-of-use assets | 37 | (0.6) | (0.1) |
Reversal of impairment – property and equipment | – | (0.7) | |
Acquisition costs | 53.3 | 11.8 | |
Integration costs | 19.7 | 10.2 | |
Restructuring and reorganisation costs | 11.0 | (1.6) | |
Onerous contracts associated with COVID-19 | – | 4.7 | |
Fair value gain on contingent consideration | (87.6) | – | |
Fair value loss on contingent consideration | 12.0 | 5.7 | |
Foreign exchange loss on swap settlement | 5.6 | – | |
Credit in respect of unallocated cash | (5.3) | – | |
Adjusting items in operating profit/loss from continuing operations | 346.0 | 312.2 | |
Fair value (gain)/loss on investments | (1.3) | 0.9 | |
Profit on disposal of subsidiaries and operations | (3.0) | (11.6) | |
Distributions received from investments | – | (20.6) | |
Finance costs | 11 | 0.8 | 1.3 |
Adjusting items in profit before tax from continuing operations | 342.5 | 282.2 | |
Tax related to adjusting items | 12 | (127.0) | (54.5) |
Adjusting items in profit for the year from continuing operations | 215.5 | 227.7 |
Average number of | ||
employees | ||
2023 | 2022 | |
Informa Markets | 4,982 | 4,383 |
Informa Connect | 2,206 | 1,661 |
Informa Tech | 2,053 | 1,308 |
Taylor & Francis | 3,054 | 2,866 |
Continuing operations | 12,295 | 10,218 |
Discontinued operations | – | 563 |
Total | 12,295 | 10,781 |
Year ended 31 December 2023 | Year ended 31 December 2022 | |||||
Continuing | Discontinued | Continuing | Discontinued | |||
operations | operations | Total | operations | operations | Total | |
£m | £m | £m | £m | £m | £m | |
Wages and salaries | 782.8 | – | 782.8 | 648.4 | 38.6 | 687.0 |
Social security costs | 70.6 | – | 70.6 | 58.6 | 6.0 | 64.6 |
Pension costs associated with staff charged to operating | ||||||
profit (Note 33) | 26.4 | – | 26.4 | 21.7 | 2.3 | 24.0 |
Share-based payments (Note 9) | 20.8 | – | 20.8 | 17.1 | 1.0 | 18.1 |
Staff costs (excluding adjusting items) | 900.6 | – | 900.6 | 745.8 | 47.9 | 793.7 |
Redundancy costs | 15.5 | – | 15.5 | (0.6) | 0.5 | (0.1) |
916.1 | – | 916.1 | 745.2 | 48.4 | 793.6 |
2023 | 2022 | |
£m | £m | |
Short-term employee benefits | 2.9 | 2.9 |
Post-employment benefits | 0.2 | 0.4 |
Share-based payments | 3.2 | 3.1 |
6.3 | 6.4 |
2023 | 2022 | |
Number of | Number of | |
options | options | |
Outstanding as at 1 January | 8,202,790 | 9,349,726 |
LTIPs granted in the year | 2,798,314 | 2,548,150 |
LTIPs exercised in the year | (1,826,371) | (3,448,832) |
LTIPs lapsed in the year | (295,988) | (246,254) |
Outstanding as at 31 December | 8,878,745 | 8,202,790 |
Exercisable awards included in outstanding number of options as at 31 December | 1,468,521 | 580,324 |
2023 | 2022 | |
ShareMatch | ShareMatch | |
Number of | Number of | |
share awards | share awards | |
Outstanding as at 1 January | 1,354,338 | 1,078,742 |
Purchased in the year | 840,329 | 597,446 |
Transferred to participants in the year | (304,901) | (321,850) |
Outstanding as at 31 December | 1,889,766 | 1,354,338 |
2023 | 2022 | |
£m | £m | |
Interest income on bank deposits | 46.7 | 25.3 |
Interest income from loans receivable | – | 1.7 |
Interest income from finance lessor leases | 0.4 | 0.3 |
Fair value gain on financial instruments through the Income Statement | 0.3 | 0.2 |
Total finance income | 47.4 | 27.5 |
2023 | 2022 | ||
Notes | £m | £m | |
Interest expense on borrowings and loans | 58.2 | 61.1 | |
Interest on lease liabilities | 37 | 11.2 | 11.0 |
Interest (income)/cost on pension scheme net surplus | 33 | (1.8) | 0.7 |
Total interest expense | 67.6 | 72.8 | |
Non-income taxes in relation to intra-Group financing | 0.1 | 0.2 | |
Fair value gain on financial instruments through the Income Statement | (1.1) | (0.2) | |
Financing costs before adjusting items | 66.6 | 72.8 | |
Adjusting items | 0.8 | 1.3 | |
Total finance costs | 67.4 | 74.1 |
2023 | 2022 | |
£m | £m | |
Current tax: | ||
Current year | ||
UK | 33.2 | 17.6 |
Continental Europe | 26.0 | 14.7 |
US | (10.5) | 202.3 |
China | 25.6 | 2.9 |
Rest of world | 25.1 | 10.2 |
Prior years | (25.1) | (2.9) |
Total current tax | 74.3 | 244.8 |
Deferred tax: | ||
Current year | (36.3) | 71.7 |
Prior years | (6.6) | (3.6) |
Credit arising from tax rate changes | (2.0) | (1.3) |
Total deferred tax | (44.9) | 66.8 |
Total tax charge | 29.4 | 311.6 |
Tax charge relating to continuing operations | 29.4 | 26.7 |
Tax charge relating to discontinued operations | – | 284.9 |
Tax charge on profit on ordinary activities from continuing and discontinued operations | 29.4 | 311.6 |
Gross | Tax | Gross | Tax | ||
2023 | 2023 | 2022 | 2022 | ||
Notes | £m | £m | £m | £m | |
Intangible assets amortisation | 7 | (312.8) | 76.8 | (275.3) | 63.4 |
Benefit of goodwill amortisation for tax purposes only | – | (14.5) | – | (13.1) | |
Impairment – acquisition-related and other intangible assets | 7 | (25.1) | 6.4 | (6.9) | 1.5 |
Reversal of impairment – IFRS 16 right-of-use assets | 7 | 0.6 | (0.1) | 0.1 | 0.3 |
Reversal of impairment – property and equipment | 7 | – | – | 0.7 | (0.1) |
Acquisition and integration-related costs | 7 | (73.0) | 22.5 | (22.0) | 3.7 |
Restructuring and reorganisation costs | 7 | (11.0) | 2.7 | 1.6 | (0.1) |
Onerous contracts associated with COVID-19 | 7 | – | – | (4.7) | 1.1 |
Fair value gain on contingent consideration | 87.6 | – | – | – | |
Fair value loss on contingent consideration | 7 | (12.0) | – | (5.7) | – |
Foreign exchange loss on swap settlement | 7 | (5.6) | 1.3 | – | – |
Credit in respect of unallocated cash | 7 | 5.3 | (1.2) | – | – |
Fair value gain/(loss) on investments | 1.3 | 1.5 | (0.9) | – | |
Profit on disposal of subsidiaries and operations | 3.0 | – | 11.6 | – | |
Distributions received from investments | 7 | – | – | 20.6 | (2.5) |
Finance costs | 7 | (0.8) | 0.2 | (1.3) | 0.3 |
Movement in deferred tax asset on Luxembourg losses | – | 15.9 | – | – | |
Adjustments for prior years | – | 15.5 | – | – | |
Total tax on adjusting items from continuing operations | (342.5) | 127.0 | (282.2) | 54.5 |
2023 | 2022 | |||
£m | % | £m | % | |
Profit before tax from continuing operations | 492.1 | 168.8 | ||
Profit before tax from discontinued operations | – | 1,778.1 | ||
Total profit before tax | 492.1 | 1,946.9 | ||
Tax charge at effective UK statutory rate of 23.5% (2022: 19.0%) | 115.6 | 23.5 | 369.9 | 19.0 |
Different tax rates on overseas profits | 4.4 | 0.9 | 80.1 | 4.0 |
Disposal-related items | (1.0) | (0.2) | (128.9) | (6.6) |
Acquisition-related items | (5.2) | (1.1) | – | – |
Non-deductible expenditure | 10.7 | 2.1 | 5.4 | 0.3 |
Non-taxable income | (27.8) | (5.6) | (2.9) | (0.1) |
Benefits from financing structures | (8.1) | (1.6) | (8.1) | (0.4) |
Tax incentives | (1.4) | (0.3) | (2.1) | (0.1) |
Adjustments for prior years | (31.7) | (6.4) | (6.5) | (0.3) |
Net movement in provisions for uncertain tax positions | (11.6) | (2.4) | 6.5 | 0.3 |
Impact of changes in tax rates | (2.0) | (0.4) | (1.3) | (0.1) |
Recognition of deferred tax asset on Luxembourg losses | (15.9) | (3.2) | – | – |
Movements in other deferred tax not recognised | 3.4 | 0.7 | (0.5) | – |
Tax charge and effective rate for the year | 29.4 | 6.0 | 311.6 | 16.0 |
2023 | 2022 | |||
Pence per | 2023 | Pence per | 2022 | |
share | £m | share | £m | |
Amounts recognised as distributions to equity holders in the year: | ||||
Interim dividend for the year ended 31 December 2022 | – | – | 43.3 | |
Final dividend for the year ended 31 December 2022 | – | – | 95.7 | |
Interim dividend for the year ended 31 December 2023 | 80.9 | – | – | |
Proposed final dividend for the year ended 31 December 2023 | 166.9 | – | – | |
Total dividend for the year | 18.0 | 247.8 | 9.8 | 139.0 |
2023 | 2022 | |
Weighted average number of shares used in basic and adjusted basic earnings per share | 1,394,051,260 | 1,456,167,252 |
Effect of dilutive potential ordinary shares | 8,670,882 | 8,117,003 |
Weighted average number of shares used in diluted and adjusted diluted earnings per share | 1,402,722,142 | 1,464,284,255 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Statutory earnings per share from continuing operations | £m | Pence | £m | Pence |
Profit for the year | 462.7 | 1,635.3 | ||
Adjustments to exclude profit for the period from discontinued operations | – | (1,493.2) | ||
Earnings from continuing operations and EPS for the purpose of basic EPS | 462.7 | 142.1 | ||
Non-controlling interests | (43.7) | (3.8) | ||
Earnings from continuing operations and EPS for the purpose of statutory | ||||
basic EPS | 419.0 | 30.1 | 138.3 | 9.5 |
Effect of dilutive potential ordinary shares (p) | – | (0.2) | – | (0.1) |
Earnings from continuing operations and EPS for the purpose of statutory | ||||
diluted EPS | 419.0 | 29.9 | 138.3 | 9.4 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Statutory earnings per share from discontinued operations | £m | Pence | £m | Pence |
Profit for the year | – | 1,493.2 | ||
Non-controlling interests | – | – | ||
Earnings from discontinued operations and EPS for the purpose of statutory | ||||
basic EPS | – | – | 1,493.2 | 102.5 |
Effect of dilutive potential ordinary shares (p) | – | – | – | (0.5) |
Earnings from discontinued operations and EPS for the purpose of statutory | ||||
diluted EPS | – | – | 1,493.2 | 102.0 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Statutory earnings per share from continuing and discontinued operations | £m | Pence | £m | Pence |
Profit for the year | 462.7 | 1,635.3 | ||
Non-controlling interests | (43.7) | (3.8) | ||
Earnings and EPS for the purpose of statutory basic EPS | 419.0 | 30.1 | 1,631.5 | 112.0 |
Effect of dilutive potential ordinary shares (p) | – | (0.2) | – | (0.6) |
Earnings from continuing and discontinued operations and EPS for the purpose of statutory diluted EPS | 419.0 | 29.9 | 1,631.5 | 111.4 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Adjusted earnings per share from continuing operations | £m | Pence | £m | Pence |
Earnings for the purpose of statutory basic EPS/statutory basic EPS (p) | 419.0 | 30.1 | 138.3 | 9.5 |
Intangible asset amortisation | 312.8 | 22.4 | 275.3 | 18.9 |
Impairment – acquisition-related and other intangible assets | 25.1 | 1.8 | 6.9 | 0.5 |
Reversal of impairment – IFRS 16 right-of-use assets | (0.6) | – | (0.1) | – |
Reversal of impairment – property and equipment | – | – | (0.7) | (0.1) |
Acquisition costs | 53.3 | 3.8 | 11.8 | 0.8 |
Integration costs | 19.7 | 1.4 | 10.2 | 0.7 |
Restructuring and reorganisation costs | 11.0 | 0.8 | (1.6) | (0.1) |
Onerous contracts associated with COVID-19 | – | – | 4.7 | 0.3 |
Fair value gain on contingent consideration | (87.6) | (6.3) | – | – |
Fair value loss on contingent consideration | 12.0 | 0.9 | 5.7 | 0.4 |
Foreign exchange loss on swap settlement | 5.6 | 0.4 | – | – |
Credit in respect of unallocated cash | (5.3) | (0.4) | – | – |
Fair value (gain)/loss on investments | (1.3) | (0.1) | 0.9 | 0.1 |
Profit on disposal of subsidiaries and operations | (3.0) | (0.2) | (11.6) | (0.8) |
Distributions received from investments | – | – | (20.6) | (1.4) |
Finance costs | 0.8 | 0.1 | 1.3 | 0.1 |
Tax related to adjusting items | (127.0) | (9.1) | (54.5) | (3.7) |
Non-controlling interest adjusting items | 0.6 | – | (9.5) | (0.7) |
Earnings and EPS for the purpose of adjusted basic EPS from continuing operations | 635.1 | 45.6 | 356.5 | 24.5 |
Effect of dilutive potential ordinary shares (p) | – | (0.3) | – | (0.1) |
Earnings and EPS for the purpose of adjusted diluted EPS from continuing operations | 635.1 | 45.3 | 356.5 | 24.4 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Adjusted earnings per share from discontinued operations | £m | Pence | £m | Pence |
Earnings for the purpose of statutory basic EPS/statutory basic EPS (p) | – | – | 1,493.2 | 102.5 |
Adjusting items | – | – | (1,463.7) | (100.5) |
Earnings and EPS for the purpose of adjusted basic EPS from discontinued | ||||
operations | – | – | 29.5 | 2.0 |
Effect of dilutive potential ordinary shares (p) | – | – | – | – |
Earnings and EPS for the purpose of adjusted diluted EPS from discontinued | ||||
operations | – | – | 29.5 | 2.0 |
Per share | Per share | |||
Earnings | amount | Earnings | amount | |
2023 | 2023 | 2022 | 2022 | |
Adjusted earnings per share from continuing and discontinued operations | £m | Pence | £m | Pence |
Earnings and EPS for the purpose of adjusted basic EPS | 635.1 | 45.6 | 386.0 | 26.5 |
Effect of dilutive potential ordinary shares (p) | – | (0.3) | – | (0.1) |
Earnings and EPS for the purpose of adjusted diluted EPS | 635.1 | 45.3 | 386.0 | 26.4 |
£m | |
Cost | |
At 1 January 2022 | 6,378.7 |
Additions in the year | 321.4 |
Disposals | (593.9) |
Exchange difference | 453.0 |
At 1 January 2023 | 6,559.2 |
Additions in the year (Note 17) | 998.1 |
Exchange differences | (275.7) |
At 31 December 2023 | 7,281.6 |
Accumulated impairment losses | |
At 1 January 2022 | (661.7) |
Disposals | 37.5 |
Exchange differences | (54.7) |
At 1 January 2023 | (678.9) |
Exchange differences | 27.1 |
At 31 December 2023 | (651.8) |
Carrying amount | |
At 31 December 2023 | 6,629.8 |
At 31 December 2022 | 5,880.3 |
Goodwill | Goodwill | |||
carrying | carrying | |||
amount | amount | |||
31 December | 31 December | Number of | Number of | |
2023 | 2022 | CGUs | CGUs | |
CGU groups | £m | £m | 2023 | 2022 |
Informa Markets | 4,211.5 | 3,869.2 | 5 | 6 |
Informa Connect | 1,023.3 | 620.5 | 4 | 3 |
Informa Tech | 824.6 | 825.9 | 1 | 1 |
Taylor & Francis | 570.4 | 564.7 | 1 | 1 |
6,629.8 | 5,880.3 | 11 | 11 |
Informa Markets, Informa Connect | ||
and Taylor & Francis | Informa Tech | |
Projected cash flows | For 2024 projected cash flows, management has used the annual budget. For 2025 and 2026 management | |
has used the three-year plan forecast. A review of all forecast revenue streams has been undertaken. These | ||
forecasts include management expectations of the business’s future performance and represent the Directors’ | ||
best estimate of the future performance of these businesses. Management has considered the quantitative | ||
impact of unmitigated climate-related risks on asset recoverable amounts and concluded that this would not | ||
cause a material impact to annual cash flows. In its forecasts management has considered recent trading | ||
performance, including in the Middle East, and current market conditions when determining these estimates. | ||
Assumptions in relation to tax | All cash flows used are pre tax. | All cash flows are post tax. Income tax has been applied |
at a blended rate of 25.4%. | ||
Long-term growth rate | For the Group’s value in use calculation, a perpetual growth rate has been applied to the 2026 operating | |
cash flows. | ||
Long-term growth rates are based on external reports on long-term GDP growth rates for the main geographic | ||
markets in which each CGU group operates and therefore are not considered to exceed the long-term average | ||
growth prospects for the individual markets. Long-term growth rates have not been risk adjusted to reflect any | ||
of the uncertainties noted above, as these uncertainties are already reflected in the forecasts. | ||
Discount rate applied | We have calculated the pre-tax discount rate for | We have calculated the post-tax discount rate for each |
each of the CGUs and CGU groups. For the cost of | of the CGUs and CGU groups. For the cost of debt, we | |
debt, we have considered market rates, based on | have considered market rates, based on entities with | |
entities with a comparable credit rating. The cost of | a comparable credit rating. The cost of equity is | |
equity is calculated using the Capital Asset Pricing | calculated using the CAPM. Discount rates have not | |
Model (CAPM). Discount rates have not been risk | been risk adjusted to reflect any of the uncertainties | |
adjusted to reflect any of the uncertainties noted | noted above, as these uncertainties are already | |
above, as these uncertainties are already reflected | reflected in the forecasts. | |
in the forecasts. |
Long-term market | ||||||||
Headroom on CGU groups | growth rates | Pre-tax discount rates | Post-tax discount rates | |||||
Key assumptions | 2023 | 2022 | ||||||
and headroom | £m | £m | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
Informa Markets | 4,559.3 | 1,990.8 | 2.4% | 2.2% | 11.2% | 11.6% | n/a | n/a |
Informa Connect | 889.8 | 281.0 | 2.1% | 1.7% | 12.1% | 13.0% | n/a | n/a |
Informa Tech | 215.0 | 282.9 | 2.1% | 1.8% | n/a | 13.3% | 10.2% | n/a |
Taylor & Francis | 2,562.4 | 1,822.9 | 2.1% | 1.6% | 11.0% | 11.3% | n/a | n/a |
Database and | Exhibitions | ||||||
intellectual | and | ||||||
property, | conferences, | ||||||
Publishing | brand and | brand and | Intangible | ||||
book lists and | customer | customer | software | Product | |||
journal titles | relationships | relationships | Sub-total | assets | development | Total | |
£m | £m | £m | £m | £m | £m | £m | |
Cost | |||||||
At 1 January 2022 | 877.2 | 682.2 | 3,372.8 | 4,932.2 | 282.2 | 71.9 | 5,286.3 |
Reclassification | – | – | – | – | (6.7) | 6.9 | 0.2 |
Arising on acquisition of subsidiaries and operations | – | 188.2 | – | 188.2 | 0.5 | – | 188.7 |
Additions | 5.8 | – | 29.8 | 35.6 | 39.3 | 22.8 | 97.7 |
Disposals | – | (228.3) | (4.2) | (232.5) | (46.6) | (61.2) | (340.3) |
Exchange differences | 55.5 | 51.6 | 264.6 | 371.7 | 10.2 | 5.1 | 387.0 |
At 1 January 2023 | 938.5 | 693.7 | 3,663.0 | 5,295.2 | 278.9 | 45.5 | 5,619.6 |
Arising on acquisition of subsidiaries | |||||||
and operations | 6.8 | 40.5 | 529.8 | 577.1 | – | 1.5 | 578.6 |
Additions | 8.4 | 2.2 | 22.2 | 32.8 | 52.9 | 14.9 | 100.6 |
Disposals | – | (22.6) | (19.4) | (42.0) | (10.7) | (11.2) | (63.9) |
Exchange differences | (28.5) | (35.9) | (170.4) | (234.8) | (4.2) | (0.7) | (239.7) |
At 31 December 2023 | 925.2 | 677.9 | 4,025.2 | 5,628.3 | 316.9 | 50.0 | 5,995.2 |
Amortisation | |||||||
At 1 January 2022 | (630.0) | (450.0) | (1,102.0) | (2,182.0) | (176.9) | (43.8) | (2,402.7) |
Reclassification | – | – | – | – | 0.3 | 0.2 | 0.5 |
Charge for the year | (52.8) | (24.6) | (198.4) | (275.8) | (32.5) | (5.7) | (314.0) |
Impairment losses | – | – | (6.0) | (6.0) | (0.9) | – | (6.9) |
Disposals | – | 182.1 | 0.8 | 182.9 | 39.3 | 38.5 | 260.7 |
Exchange differences | (41.5) | (35.9) | (97.0) | (174.4) | (7.0) | (3.1) | (184.5) |
At 1 January 2023 | (724.3) | (328.4) | (1,402.6) | (2,455.3) | (177.7) | (13.9) | (2,646.9) |
Charge for the year | (52.7) | (36.5) | (223.6) | (312.8) | (35.1) | (6.0) | (353.9) |
Impairment losses | (0.2) | – | (23.5) | (23.7) | – | (1.4) | (25.1) |
Disposals | – | 22.6 | 19.4 | 42.0 | 13.8 | 7.2 | 63.0 |
Exchange differences | 23.0 | 16.9 | 65.5 | 105.4 | 2.7 | 0.5 | 108.6 |
At 31 December 2023 | (754.2) | (325.4) | (1,564.8) | (2,644.4) | (196.3) | (13.6) | (2,854.3) |
Carrying amount | |||||||
At 31 December 2023 | 171.0 | 352.5 | 2,460.4 | 2,983.9 | 120.6 | 36.4 | 3,140.9 |
At 31 December 2022 | 214.2 | 365.3 | 2,260.4 | 2,839.9 | 101.2 | 31.6 | 2,972.7 |
2023 | 2022 | |
Cash paid on acquisitions, net of cash acquired | £m | £m |
Current year acquisitions | ||
Tarsus | 144.3 | – |
Winsight | 296.8 | – |
HIMSS Global Health Conference & Exhibition | 84.0 | – |
Canalys | 37.7 | – |
LSX | 7.5 | – |
Future Science Group | 22.4 | – |
Prior year acquisitions including deferred and contingent payments | ||
Black Arts | 2.2 | 1.4 |
Other | 1.8 | – |
Industry Dive | – | 302.2 |
Skipta | – | 4.9 |
China Bakery | – | 1.5 |
Clinerion AG | – | 2.3 |
Premiere Shows | – | 0.4 |
NetLine Corporation | – | 2.4 |
Total cash paid in year, net of cash acquired | 596.7 | 315.1 |
Provisional | Provisional | ||
fair value | Adjustments | fair value | |
£m | £m | £m | |
Acquisition intangible assets | 361.1 | – | 361.1 |
Property and equipment | 2.7 | 0.2 | 2.9 |
Investments in joint ventures | 22.3 | – | 22.3 |
Trade and other receivables | 45.9 | 0.6 | 46.5 |
Cash and cash equivalents | 29.6 | (0.5) | 29.1 |
Trade and other payables | (81.9) | 5.3 | (76.6) |
Borrowings | (443.9) | – | (443.9) |
Deferred income | (90.1) | – | (90.1) |
Provisions | (5.7) | – | (5.7) |
Current tax liabilities | (7.7) | – | (7.7) |
Deferred tax liabilities | (55.9) | – | (55.9) |
Total identifiable net liabilities assumed | (223.6) | 5.6 | (218.0) |
Non-controlling interest | (87.2) | – | (87.2) |
Provisional goodwill | 670.2 | (5.6) | 664.6 |
Total consideration | 359.4 | – | 359.4 |
Provisional | |
fair value | |
£m | |
Acquisition intangible assets | 163.4 |
Other intangible assets | 1.5 |
Property and equipment | 1.8 |
Trade and other receivables | 6.9 |
Cash and cash equivalents | 17.9 |
Right-of-use assets | 3.9 |
Finance lease receivables | 0.3 |
Other receivables | 0.3 |
Finance lease liabilities | (4.2) |
Trade and other payables | (2.3) |
Deferred income | (36.2) |
Provisions | (1.2) |
Current tax liabilities | (1.5) |
Deferred tax liabilities | (8.9) |
Total identifiable net assets acquired | 141.7 |
Provisional goodwill | 182.7 |
Total consideration | 324.4 |
Provisional | |
fair value | |
£m | |
Acquisition intangible assets | 25.7 |
Trade and other receivables | 0.4 |
Trade and other payables | (3.8) |
Deferred income | (6.4) |
Total identifiable net assets acquired | 15.9 |
Provisional goodwill | 68.1 |
Total consideration | 84.0 |
Provisional | |
fair value | |
£m | |
Acquisition intangible assets | 11.0 |
Trade and other receivables | 4.1 |
Cash and cash equivalents | 3.8 |
Property and equipment | 0.1 |
Right-of-use assets | 0.6 |
Trade and other payables | (1.2) |
Deferred income | (5.5) |
Lease liabilities | (0.6) |
Current tax liabilities | (0.2) |
Deferred tax liabilities | (2.8) |
Total identifiable net assets acquired | 9.3 |
Provisional goodwill | 39.3 |
Total consideration | 48.6 |
Freehold | Leasehold | Equipment, | ||
land and | land and | fixtures and | Total property | |
buildings | buildings | fittings | and | |
£m | £m | £m | equipment £m | |
Cost | ||||
At 1 January 2022 | 3.1 | 55.3 | 43.7 | 102.1 |
Additions | – | 1.1 | 13.2 | 14.3 |
Acquisitions | – | 0.5 | – | 0.5 |
Disposals | – | (8.6) | (12.9) | (21.5) |
Exchange differences | 0.1 | 4.2 | 5.6 | 9.9 |
At 1 January 2023 | 3.2 | 52.5 | 49.6 | 105.3 |
Additions | 0.2 | 14.7 | 16.5 | 31.4 |
Acquisitions | 0.2 | – | 4.6 | 4.8 |
Disposals | (0.1) | (20.6) | (8.7) | (29.4) |
Exchange differences | (0.1) | (2.2) | (6.0) | (8.3) |
At 31 December 2023 | 3.4 | 44.4 | 56.0 | 103.8 |
Depreciation | ||||
At 1 January 2022 | (0.7) | (25.2) | (34.7) | (60.6) |
Charge for the year | – | (4.5) | (7.2) | (11.7) |
Disposals | – | 8.5 | 12.2 | 20.7 |
Impairment reversal | – | 0.7 | 0.1 | 0.8 |
Exchange differences | – | (2.4) | (4.2) | (6.6) |
At 1 January 2023 | (0.7) | (22.9) | (33.8) | (57.4) |
Charge for the year | (0.2) | (4.3) | (9.0) | (13.5) |
Disposals | 0.1 | 16.0 | 8.0 | 24.1 |
Exchange differences | – | 1.5 | 2.3 | 3.8 |
At 31 December 2023 | (0.8) | (9.7) | (32.5) | (43.0) |
Carrying amount | ||||
At 31 December 2023 | 2.6 | 34.7 | 23.5 | 60.8 |
At 31 December 2022 | 2.5 | 29.6 | 15.8 | 47.9 |
2023 | 2022 | |
£m | £m | |
At 1 January | 35.5 | 29.1 |
Arising on acquisition of associates | – | 2.0 |
Arising on acquisition of joint ventures | 22.3 | – |
Arising on transfer from other investments | – | 3.9 |
Arising on transfer to subsidiaries | (1.8) | – |
Dividends received from associates | (1.4) | (1.8) |
Share of profit of associates | 2.5 | 2.0 |
Share of profit of joint ventures | 1.8 | – |
Foreign exchange (loss)/gain | (0.1) | 0.3 |
At 31 December | 58.8 | 35.5 |
Country of | |||||
incorporation | Shareholding | ||||
and | Class of | or share of | Registered | ||
Company | Divisions | operation | shares held | operation | office |
Independent Materials Handling Exhibitions Limited | Informa Markets | UK | Ordinary | 50% | UK1 |
GML Exhibition (Thailand) Co. Ltd | Informa Markets | Thailand | Ordinary | 49% | TH1 |
Cosmoprof India Private Limited | Informa Markets | India | Ordinary | 50% | IN1 |
Lloyd's Maritime Information Services Ltd | Informa Connect | UK | Ordinary | 50% | UK2 |
Shanghai Intex Exhibition Co., Ltd | Informa Markets | China | Ordinary | 50% | CH1 |
Tarsus Asia Exhibitions Pte. Ltd | Informa Markets | Singapore | Ordinary | 50% | SG1 |
Tak Mexico Holdings, LLC | Informa Markets | US | Ordinary | 50% | US1 |
Tarsus RAI Events, LLC | Informa Markets | US | Ordinary | 50% | US1 |
Country of | ||||||
incorporation | Shareholding | |||||
and | or share of | Accounting | Registered | |||
Company | Divisions | operation | Class of shares held | operation | year end | office |
Maritime Insights & Intelligence Limited | Informa Markets | UK | Ordinary | 20.0% | 31 December | UK3 |
Independent Television News Limited | Informa Markets | UK | Ordinary | 20.0% | 31 December | UK4 |
PA Media Group Ltd | Informa Markets | UK | Ordinary | 18.2% | 31 December | UK5 |
Guangdong International Exhibitions Ltd | Informa Markets | China | Ordinary | 27.5% | 31 December | CH2 |
Bridge Events Technologies Limited | Informa Connect | UK | Ordinary | 14.9% | 31 December | UK6 |
Founders Forum LLP | Informa Tech | UK | Membership Interest | 22.3% | 31 December | UK7 |
Registered office | Registered office address | ||
CH1 | Floor 11, New Town Mansion, 55 Lou Shan Guan Road, Shanghai 200336, China | ||
CH2 | 5th Floor, Building A121, Guang Yuan Road (West), Guangzhou 510400, China | ||
IN1 | Solitaire-XIV Building, B-Wing, 1st Floor, Unit No. 3 & 4, Guru Hargovindji Marg, Chakala, Andheri (East), | ||
Mu | mbai 400093 | , India | |
SG1 | 9 Raffles Place, #26-01, Republic Plaza, Singapore 048619 | ||
TH1 | 428 | Ari Hills Building, 18th Floor, Phahonyothin Road, Samsen Nai, Phaya Thai, Bangkok 10400, Thailand | |
UK1 | 5 Howick Place, London, SW1P 1WG, United Kingdom | ||
UK2 | 71 Fenchurch Street, London, EC3M 4BS, United Kingdom | ||
UK3 | 5th Floor, 10 St. Bride Street, London, EC4A 4AD, United Kingdom | ||
UK4 | 200 | Grays Inn Road, London, WC1X 8XZ, United Kingdom | |
UK5 | 37 North Wharf Road, London, W2 1AF, United Kingdom | ||
UK6 | 4th Floor, 4 Tabernacle Street, London, EC2A 4LU, United Kingdom | ||
UK7 | 6th Floor, 180 Strand, 2 Arundel Street, London, WC2R 3DA, United Kingdom | ||
US1 | c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington DE, 19801, USA |
2023 | 2022 | |
£m | £m | |
At 1 January | 262.7 | 6.1 |
Additions of unlisted equity securities in year | – | 166.5 |
Additions of listed equity securities in year | 24.9 | – |
Conversion of convertible bonds to investments | (20.6) | – |
Addition of preference shares | – | 72.9 |
Addition of convertible bond | – | 22.2 |
Transfer to associates | – | (3.9) |
Fair value gain/(loss) | 2.5 | (8.4) |
Foreign exchange (loss)/gain | (8.7) | 7.3 |
At 31 December | 260.8 | 262.7 |
Consolidated | Consolidated Income | |||
Balance Sheet at | Statement year ended | |||
31 December | 31 December | |||
2023 | 2022 | 2023 | 2022 | |
£m | £m | £m | £m | |
Accelerated tax depreciation | (6.1) | 3.3 | (10.0) | 0.7 |
Intangibles | 647.4 | 633.4 | (40.8) | (39.9) |
Pensions | (1.6) | (1.7) | – | 0.7 |
Losses | (69.4) | (71.7) | 3.7 | 100.3 |
Other | (47.0) | (32.2) | 2.2 | 5.0 |
523.3 | 531.1 | (44.9) | 66.8 |
2023 | 2022 | |
£m | £m | |
Net deferred tax liability at 1 January | 531.1 | 421.8 |
Credit to other comprehensive income for the year | – | (2.6) |
Acquisitions and additions | 62.5 | 35.7 |
Disposals | – | (20.3) |
(Credit)/charge to profit or loss for the year | (44.9) | 66.8 |
Foreign exchange and other movements | (25.4) | 29.7 |
Net deferred tax liability at 31 December | 523.3 | 531.1 |
2023 | 2022 | |
£m | £m | |
Deferred tax liability | 540.9 | 532.9 |
Deferred tax asset | (17.6) | (1.8) |
523.3 | 531.1 |
2023 | 2022 | |
£m | £m | |
Current | ||
Trade receivables | 372.2 | 334.4 |
Less: provision | (30.5) | (45.0) |
Trade receivables net | 341.7 | 289.4 |
Other receivables | 60.9 | 42.0 |
Accrued income | 44.3 | 43.9 |
Prepayments | 100.0 | 85.1 |
Total current | 546.9 | 460.4 |
Non-current | ||
Other receivables | 32.7 | 50.3 |
Less: provision | (0.1) | (0.6) |
Other receivables net | 32.6 | 49.7 |
579.5 | 510.1 |
2023 | 2022 | |
£m | £m | |
Financial assets – current | ||
Currency forwards | 0.6 | – |
0.6 | – | |
Financial assets – non-current | ||
Currency forwards | – | 2.2 |
– | 2.2 | |
Financial liabilities – current | ||
Currency forwards | – | (1.1) |
– | (1.1) | |
Financial liabilities – non-current | ||
Cross currency swaps designated in a hedging relationship | (77.9) | (168.1) |
(77.9) | (168.1) |
2023 | 2022 | |
£m | £m | |
Work in progress | 15.0 | 6.6 |
Finished goods and goods for resale | 21.2 | 22.2 |
36.2 | 28.8 |
2023 | 2022 | |
£m | £m | |
(Decrease)/increase in cash and cash equivalents in the year (including cash acquired) | (1,689.2) | 1,158.4 |
Cash flows from net drawdown of borrowings, derivatives and lease liabilities associated with debt | 879.7 | 244.8 |
Change in net debt resulting from cash flows | (809.5) | 1,403.2 |
Non-cash movements including foreign exchange | (365.2) | (201.4) |
Movement in net debt in the period | (1,174.7) | 1,201.8 |
Net debt at beginning of the year | (244.6) | (1,434.6) |
Net lease additions in the year | (37.1) | (11.8) |
Net debt at end of the year | (1,456.4) | (244.6) |
At | At | ||||
1 January | Non-cash | Exchange | 31 December | ||
2023 | Movements | Cash flow | movements | 2023 | |
£m | £m | £m | £m | £m | |
Cash and cash equivalents | 2,125.8 | – | (1,689.2) | (47.3) | 389.3 |
Other financing assets | |||||
Derivative assets associated with borrowings | 2.2 | (2.2) | – | – | – |
Finance lease receivables | 6.7 | 5.9 | (1.3) | (0.8) | 10.5 |
Total other financing assets | 8.9 | 3.7 | (1.3) | (0.8) | 10.5 |
Other financing liabilities | |||||
Bond borrowings due in more than one year | (1,512.3) | – | – | 19.7 | (1,492.6) |
Bank loans due in more than one year | (41.3) | 0.5 | 7.9 | 2.5 | (30.4) |
Bond borrowing fees | 8.8 | (2.7) | – | 0.1 | 6.2 |
Bank loan fees due in more than one year | 2.4 | (1.6) | 1.2 | 0.3 | 2.3 |
Derivative liabilities associated with borrowings | (168.1) | 82.0 | 8.2 | – | (77.9) |
Lease liabilities | (270.4) | (43.0) | 33.8 | 15.8 | (263.8) |
Acquired debt (Note 17) | – | (443.9) | 443.9 | – | – |
Bond borrowings due in less than one year | (398.4) | – | 386.0 | 12.4 | – |
Total other financing liabilities | (2,379.3) | (408.7) | 881.0 | 50.8 | (1,856.2) |
Total net financing liabilities | (2,370.4) | (405.0) | 879.7 | 50.0 | (1,845.7) |
Net debt | (244.6) | (405.0) | (809.5) | 2.7 | (1,456.4) |
At | At | ||||
1 January | Non-cash | Exchange | 31 December | ||
2022 | Movements | Cash flow | movements | 2022 | |
£m | £m | £m | £m | £m | |
Cash and cash equivalents | 884.8 | – | 1,158.4 | 82.6 | 2,125.8 |
Other financing assets | |||||
Derivative assets associated with borrowings | 3.4 | (1.2) | – | – | 2.2 |
Finance lease receivables | 6.4 | 1.9 | (1.5) | (0.1) | 6.7 |
Total other financing assets | 9.8 | 0.7 | (1.5) | (0.1) | 8.9 |
Other financing liabilities | |||||
Bond borrowings due in more than one year | (2,001.3) | 398.4 | 177.2 | (86.6) | (1,512.3) |
Bank loans due in more than one year | (36.8) | – | 0.4 | (4.9) | (41.3) |
Bond borrowing fees | 12.1 | (3.3) | – | – | 8.8 |
Bank loan fees due in more than one year | 3.4 | (1.1) | – | 0.1 | 2.4 |
Derivative liabilities associated with borrowings | (40.7) | (127.4) | – | – | (168.1) |
Lease liabilities | (265.9) | (13.7) | 32.1 | (22.9) | (270.4) |
Acquired debt (Note 17) | – | (36.6) | 36.6 | – | – |
Bond borrowings due in less than one year | – | (398.4) | – | – | (398.4) |
Total other financing liabilities | (2,329.2) | (182.1) | 246.3 | (114.3) | (2,379.3) |
Total net financing liabilities | (2,319.4) | (181.4) | 244.8 | (114.4) | (2,370.4) |
Net debt | (1,434.6) | (181.4) | 1,403.2 | (31.8) | (244.6) |
2023 | 2022 | |
£m | £m | |
Cash and cash equivalents | 389.3 | 2,125.8 |
2023 | 2022 | ||
Notes | £m | £m | |
Current | |||
Euro Medium Term Note (€450.0m) – due July 2023 | – | 398.4 | |
Total current borrowings | 25 | – | 398.4 |
Non-current | |||
Bank borrowings – other | 30.4 | 41.3 | |
Bank debt issue costs | (2.3) | (2.4) | |
Bank borrowings – non-current | 25 | 28.1 | 38.9 |
Euro Medium Term Note (€700.0m) – due October 2025 | 608.2 | 619.7 | |
Euro Medium Term Note (£450.0m) – due July 2026 | 450.0 | 450.0 | |
Euro Medium Term Note (€500.0m) – due April 2028 | 434.4 | 442.6 | |
Euro Medium Term Note issue costs | (6.2) | (8.8) | |
Euro Medium Term Note borrowings – non-current | 25 | 1,486.4 | 1,503.5 |
Total non-current borrowings | 1,514.5 | 1,542.4 | |
Total borrowings | 1,514.5 | 1,940.8 |
Acquisition | Onerous | |||||
and | Property | Restructuring | contract | Other | ||
integration | leases | provision | provision | provision | Total | |
£m | £m | £m | £m | £m | £m | |
At 1 January 2022 | 0.3 | 30.5 | 0.8 | 1.6 | 18.5 | 51.7 |
Increase in year | 25.8 | 4.1 | 0.8 | 18.7 | 9.8 | 59.2 |
Acquisitions of subsidiaries | – | – | – | – | 9.7 | 9.7 |
Utilisation | (22.9) | (5.5) | (0.4) | (3.5) | (5.7) | (38.0) |
Release | (3.2) | (11.1) | (0.9) | (0.8) | (4.0) | (20.0) |
At 1 January 2023 | – | 18.0 | 0.3 | 16.0 | 28.3 | 62.6 |
Increase in year | 75.1 | 12.2 | 24.8 | 0.5 | 7.2 | 119.8 |
Acquisitions of subsidiaries | – | 0.1 | 0.2 | – | 7.4 | 7.7 |
Utilisation | (47.5) | (4.5) | (16.7) | (16.0) | (5.0) | (89.7) |
Release | (11.7) | (15.7) | – | – | (1.4) | (28.8) |
At 31 December 2023 | 15.9 | 10.1 | 8.6 | 0.5 | 36.5 | 71.6 |
2023 | ||||||
Current liabilities | 15.9 | 0.5 | 8.5 | 0.5 | 12.7 | 38.1 |
Non-current liabilities | – | 9.6 | 0.1 | – | 23.8 | 33.5 |
2022 | ||||||
Current liabilities | – | 4.7 | 0.3 | 16.0 | 9.1 | 30.1 |
Non-current liabilities | – | 13.3 | – | – | 19.2 | 32.5 |
Contingent | |
consideration | |
£m | |
At 1 January 2022 | 14.7 |
Fair value loss through profit/loss | 5.7 |
Acquisitions of subsidiaries | 126.1 |
Utilisation | (9.3) |
Currency translation | (3.9) |
At 1 January 2023 | 133.3 |
Fair value gain through profit or loss | (87.6) |
Fair value loss through profit or loss | 12.0 |
Fair value gain through equity on put call options | (1.5) |
Acquisitions of subsidiaries (Note 17) | 45.4 |
Acquisitions of assets | 5.0 |
Amounts assumed at acquisition date (Note 17) | 56.5 |
Transfers | (13.1) |
Utilisation | (9.3) |
Currency translation | (2.8) |
At 31 December 2023 | 137.9 |
2023 | |
Current liabilities | 28.6 |
Non-current liabilities | 109.3 |
2022 | |
Current liabilities | 4.1 |
Non-current liabilities | 129.2 |
2023 | 2022 | |
£m | £m | |
Current | ||
Trade payables | 108.2 | 139.2 |
Other payables | 53.8 | 74.4 |
Deferred consideration | 3.7 | 0.6 |
Accruals | 379.1 | 372.7 |
Share buyback liability | 90.9 | 75.0 |
Total current | 635.7 | 661.9 |
Non-current | ||
Other payables | 13.6 | 15.8 |
Deferred consideration | 11.3 | 0.5 |
Total non-current | 24.9 | 16.3 |
660.6 | 678.2 |
2023 | 2022 | |
£m | £m | |
Total current | 972.8 | 834.5 |
Total non-current | 7.6 | 2.3 |
Total | 980.4 | 836.8 |
2023 | 2022 | ||
Notes | £m | £m | |
Financial assets | |||
Trade receivables | 21 | 341.7 | 289.4 |
Other receivables | 21 | 93.5 | 91.7 |
Finance lease receivables | 37 | 10.5 | 6.7 |
Cash and cash equivalents – at amortised cost | 26 | 248.3 | 800.8 |
Cash and cash equivalents – at fair value | 26 | 141.0 | 1,325.0 |
Derivative assets | 22 | 0.6 | 2.2 |
Other investments | 19 | 260.8 | 262.7 |
Total financial assets | 1,096.4 | 2,778.5 | |
Financial liabilities | |||
Bank borrowings | 27 | 28.1 | 38.9 |
Bond borrowings | 27 | 1,486.4 | 1,901.9 |
Lease liabilities | 37 | 263.8 | 270.4 |
Derivative liabilities | 22 | 77.9 | 169.2 |
Trade payables | 30 | 108.2 | 139.2 |
Accruals | 30 | 260.7 | 215.7 |
Other payables | 30 | 67.4 | 90.2 |
Share buyback liability | 30 | 90.9 | 75.0 |
Deferred consideration | 30 | 15.0 | 1.1 |
Contingent consideration | 29 | 137.9 | 133.3 |
Total financial liabilities | 2,536.3 | 3,034.9 |
2023 | 2022 | |||||||
Non-interest | Non-interest | |||||||
Fixed rate | Floating rate | bearing | Total | Fixed rate | Floating rate | bearing | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | |
Bank borrowings | – | 28.1 | – | 28.1 | – | 38.9 | – | 38.9 |
Bond borrowings | 1,486.4 | – | – | 1,486.4 | 1,901.9 | – | – | 1,901.9 |
Lease liabilities | 263.8 | – | – | 263.8 | 270.4 | – | – | 270.4 |
Derivatives liabilities | 77.9 | – | – | 77.9 | 169.2 | – | – | 169.2 |
Trade payables | – | – | 108.2 | 108.2 | – | – | 139.2 | 139.2 |
Accruals | – | – | 260.7 | 260.7 | – | – | 215.7 | 215.7 |
Other payables | – | – | 67.4 | 67.4 | – | – | 90.2 | 90.2 |
Share buyback liability | – | – | 90.9 | 90.9 | – | – | 75.0 | 75.0 |
Deferred consideration | – | – | 15.0 | 15.0 | – | – | 1.1 | 1.1 |
Contingent consideration | – | – | 137.9 | 137.9 | – | – | 133.3 | 133.3 |
1,828.1 | 28.1 | 680.1 | 2,536.3 | 2,341.5 | 38.9 | 654.5 | 3,034.9 |
Assets | Liabilities | |||
2023 | 2022 | 2023 | 2022 | |
£m | £m | £m | £m | |
USD | 645.8 | 1,421.1 | (823.1) | (1,074.1) |
EUR | 68.8 | 37.4 | (1,166.5) | (1,989.8) |
CNY | 139.2 | 104.4 | (138.5) | (89.3) |
Other | 271.4 | 1,144.8 | (1,153.8) | (520.5) |
1,125.2 | 2,707.7 | (3,281.9) | (3,673.7) |
Average rate | Closing rate | |||
2023 | 2022 | 2023 | 2022 | |
USD | 1.24 | 1.24 | 1.27 | 1.21 |
Euro | 1.15 | 1.17 | 1.15 | 1.13 |
2023 | 2022 | |
£m | £m | |
Cross currency swaps – derivative financial assets | – | – |
Cross currency swaps – derivative financial liabilities | (77.9) | (168.1) |
Gross | Provision | Gross | Provision | |
2023 | 2023 | 2022 | 2022 | |
£m | £m | £m | £m | |
Not past due | 151.0 | – | 152.6 | – |
Past due 0–30 days | 96.9 | – | 85.0 | – |
Past due over 31 days | 124.3 | (21.2) | 96.8 | (29.0) |
372.2 | (21.2) | 334.4 | (29.0) | |
Books return provision (see below) | – | (9.3) | – | (16.0) |
Total | 372.2 | (30.5) | 334.4 | (45.0) |
2023 | 2022 | |
£m | £m | |
1 January | 45.0 | 49.1 |
Provision recognised | 5.4 | 18.3 |
Receivables written off as uncollectible | (5.6) | (9.6) |
Amounts recovered during the year | (14.3) | (12.8) |
31 December | 30.5 | 45.0 |
2023 | 2022 | |
£m | £m | |
1 January | 0.6 | 6.8 |
Provision released | (0.5) | (6.2) |
31 December | 0.1 | 0.6 |
Carrying | Contractual | Less than | Greater than | |||
amount | cash flows | 1 year | 1 –2 years | 2–5 years | 5 years | |
£m | £m | £m | £m | £m | £m | |
31 December 2023 | ||||||
Non-derivative financial assets | ||||||
Finance lease receivable | 10.5 | 10.7 | 2.2 | 2.0 | 6.5 | – |
Non-interest bearing | 1,008.6 | 1,008.6 | 960.4 | 48.2 | – | – |
Maritime preference shares | 76.7 | 109.8 | – | – | 109.8 | – |
1,095.8 | 1,129.1 | 962.6 | 50.2 | 116.3 | – | |
Derivative financial assets | ||||||
Currency forwards | 0.6 | 0.6 | 0.6 | – | – | – |
Total financial assets | 1,096.4 | 1,129.7 | 963.2 | 50.2 | 116.3 | – |
31 December 2022 | ||||||
Non-derivative financial assets | ||||||
Finance lease receivable | 6.7 | 7.5 | 1.9 | 1.2 | 3.6 | 0.8 |
Non-interest bearing | 2,674.5 | 2,674.5 | 2,647.5 | 49.8 | – | – |
Maritime preference shares | 72.9 | 109.8 | – | – | 109.8 | – |
Convertible bond | 22.2 | 29.7 | 1.3 | 1.3 | 3.9 | 23.2 |
2,776.3 | 2,821.5 | 2,627.9 | 52.3 | 117.3 | 24.0 | |
Derivative financial assets | ||||||
Currency forwards | 2.2 | 2.2 | 2.2 | – | – | – |
Total financial assets | 2,778.5 | 2,823.7 | 2,630.1 | 52.3 | 117.3 | 24.0 |
Carrying | Contractual | Less than | Greater than | |||
amount | cash flows | 1 year | 1 –2 years | 2–5 years | 5 years | |
£m | £m | £m | £m | £m | £m | |
31 December 2023 | ||||||
Non-derivative financial liabilities | ||||||
Bank borrowings | (28.1) | (40.0) | (3.5) | (3.5) | (33.0) | – |
Bond borrowings | (1,486.4) | (1,574.3) | (32.4) | (638.0) | (903.9) | – |
Lease liabilities | (263.8) | (386.5) | (38.9) | (37.9) | (92.5) | (217.2) |
Trade and other payables | (527.2) | (527.2) | (513.6) | (13.6) | – | – |
Deferred consideration | (15.0) | (15.0) | (3.7) | – | (11.3) | – |
Contingent consideration | (137.9) | (111.9) | (28.6) | (8.8) | (74.5) | – |
(2,458.4) | (2,654.9) | (620.7) | (701.8) | (1,115.2) | (217.2) | |
Derivative financial liabilities | ||||||
Cross currency swaps – receipts | (77.9) | 1,574.7 | 32.4 | 638.2 | 904.1 | – |
Cross currency swaps – payments | (1,695.8) | (57.4) | (698.3) | (940.1) | – | |
(77.9) | (121.1) | (25.0) | (60.1) | (36.0) | – | |
Total financial liabilities | (2,536.3) | (2,776.0) | (645.7) | (761.9) | (1,151.2) | (217.2) |
31 December 2022 | ||||||
Non-derivative financial liabilities | ||||||
Bank borrowings | (38.9) | (56.0) | (3.9) | (4.4) | (47.7) | – |
Bond borrowings | (1,901.9) | (2,029.2) | (434.2) | (32.8) | (1,117.9) | (444.3) |
Lease liabilities | (270.4) | (381.3) | (40.4) | (33.2) | (81.6) | (226.1) |
Trade and other payables | (520.1) | (520.1) | (502.4) | (17.7) | – | – |
Deferred consideration | (1.1) | (1.1) | (0.6) | – | (0.5) | – |
Contingent consideration | (133.3) | (133.3) | (4.1) | (3.8) | (125.4) | – |
(2,865.7) | (3,121.0) | (985.6) | (91.9) | (1,373.1) | (670.4) | |
Derivative financial liabilities | ||||||
Currency forwards | (1.1) | (1.1) | (1.1) | – | – | – |
Cross currency swaps – receipts | (168.1) | 1,761.6 | 166.6 | 32.8 | 1,117.7 | 444.5 |
Cross currency swaps – payments | (1,998.2) | (208.0) | (60.3) | (1,267.9) | (462.0) | |
(169.2) | (237.7) | (42.5) | (27.5) | (150.2) | (17.5) | |
Total financial liabilities | (3,034.9) | (3,358.7) | (1,028.1) | (119.4) | (1,523.3) | (687.9) |
Level 1 | Level 2 | Level 3 | Total | |
2023 | 2023 | 2023 | 2023 | |
£m | £m | £m | £m | |
Financial assets | ||||
Unhedged derivative financial instruments | – | 0.6 | – | 0.6 |
Cash and cash equivalents measured at fair value | 141.0 | – | – | 141.0 |
Other investments (Note 19) | – | 28.3 | 232.5 | 260.8 |
141.0 | 28.9 | 232.5 | 402.4 | |
Financial liabilities at fair value through profit or loss and through equity | ||||
Derivative financial instruments in designated hedge accounting relationships | – | 77.9 | – | 77.9 |
Deferred consideration on acquisitions | – | – | 15.0 | 15.0 |
Contingent consideration on acquisitions (Note 29) | – | – | 137.9 | 137.9 |
– | 77.9 | 152.9 | 230.8 |
Level 1 | Level 2 | Level 3 | Total | |
2022 | 2022 | 2022 | 2022 | |
£m | £m | £m | £m | |
Financial assets | ||||
Unhedged derivative financial instruments | – | 2.2 | – | 2.2 |
Cash and cash equivalents measured at fair value | 1,325.0 | – | – | 1.325.0 |
Other investments (Note 19) | – | – | 262.7 | 262.7 |
1,325.0 | 2.2 | 262.7 | 1,589.9 | |
Financial liabilities at fair value through profit or loss | ||||
Derivative financial instruments in designated hedge accounting relationships | – | 168.1 | – | 168.1 |
Unhedged derivative financial instruments | – | 1.1 | – | 1.1 |
Deferred consideration on acquisitions | – | – | 1.1 | 1.1 |
Contingent consideration on acquisitions (Note 29) | – | – | 133.3 | 133.3 |
– | 169.2 | 134.4 | 303.6 |
Carrying | Estimated | Carrying | Estimated fair | |
amount | fair value | amount | value | |
31 December | 31 December | 31 December | 31 December | |
2023 | 2023 | 2022 | 2022 | |
£m | £m | £m | £m | |
Financial liabilities | ||||
Bond borrowings | 1,486.4 | 1,417.1 | 1,901.9 | 1,759.1 |
Total | 1,486.4 | 1,417.1 | 1,901.9 | 1,759.1 |
2023 | 2022 | ||
Notes | £m | £m | |
Continuing operations | |||
Profit before tax | 492.1 | 168.8 | |
Adjustments for: | |||
Depreciation of property and equipment | 18 | 13.5 | 11.7 |
Depreciation of right-of-use assets | 37 | 26.3 | 24.8 |
Amortisation of other intangible assets | 16 | 353.9 | 310.5 |
Impairment – acquisition-related and other intangible assets | 16 | 25.1 | 6.9 |
Reversal of impairment – IFRS 16 right-of-use assets | 37 | (0.6) | (0.1) |
Reversal of impairment – property and equipment | 7 | – | (0.7) |
Share-based payments | 9 | 20.8 | 17.5 |
Fair value gain on contingent consideration | 7 | (87.6) | – |
Fair value loss on contingent consideration | 7 | 12.0 | 5.7 |
Lease modifications | (5.1) | (3.0) | |
Profit on disposal of businesses | 7 | (3.0) | (11.6) |
Distributions received from investments | 7 | – | (20.6) |
Loss on disposal of property, equipment and software | 2.4 | 0.3 | |
Fair value (gain)/loss on investment | 7 | (1.3) | 0.9 |
Finance income | 10 | (47.4) | (27.5) |
Finance costs | 11 | 67.4 | 74.1 |
Share of adjusted results of joint ventures and associates | 19 | (5.8) | (2.1) |
Operating cash inflow before movements in working capital | 862.7 | 555.6 | |
(Increase)/decrease in inventories | (7.4) | 0.1 | |
Increase in receivables | (16.1) | (141.7) | |
(Decrease)/increase in payables | (16.0) | 197.2 | |
Movements in working capital | (39.5) | 55.6 | |
Pension deficit recovery contributions | 33 | (3.5) | (6.9) |
Additional pension payment | – | (16.1) | |
Pension payment into escrow | – | (28.2) | |
Cash generated by continuing operations | 819.7 | 560.0 | |
Cash generated by discontinued operations | – | 54.7 | |
Cash generated by operations | 819.7 | 614.7 |
Total net | |||
financing | Share buyback | ||
liabilities | liability | Total financing | |
(Note 25) | (Note 30) | cash flows | |
£m | £m | £m | |
At 1 January 2022 | (2,319.4) | – | (2,319.4) |
Non-cash movements | (181.4) | (75.0) | (256.4) |
Cash flow | 244.8 | – | 244.8 |
Exchange movements | (114.4) | – | (114.4) |
At 1 January 2023 | (2,370.4) | (75.0) | (2,445.4) |
Non-cash movements | (405.0) | (90.9) | (495.9) |
Cash flow | 879.7 | 75.0 | 954.7 |
Exchange movements | 50.0 | – | 50.0 |
At 31 December 2023 | (1,845.7) | (90.9) | (1,936.6) |
2023 | 2022 | |||||
Informa FSS | UBMPS and | Informa FSS | UBMPS and | |||
and T&F | UNEPS | Penton | and T&F | UNEPS | Penton | |
Schemes | Schemes | Scheme | Schemes | Schemes | Schemes | |
Overall duration (years) | 15 | 11 | 11 | 16 | 11 | 11 |
2023 | 2022 | |||||
Informa FSS | UBMPS and | Informa FSS | UBMPS and | |||
and T&F | UNEPS | Penton | and T&F | UNEPS | Penton | |
Schemes | Schemes | Scheme | Schemes | Schemes | Schemes | |
Discount rate | 4.60% | 4.60% | 4.75% | 4.95% | 4.95% | 4.95% |
Rate of price inflation | 2.45% (CPI) | 2.45% (CPI) | n/a | 2.45% (CPI) | 2.45% (CPI) | n/a |
3.05% (RPI) | 3.05% (RPI) | n/a | 3.15% (RPI) | 3.15% (RPI) | n/a | |
Rate of increase for deferred pensions | 2.00% | 2.00% | n/a | 1.90% | 1.90% | n/a |
Rate of increase for pensions in payment | 2.00–2.90% | 2.00–2.90% | n/a | 1.90–2.90% | 1.90–2.90% | n/a |
Life expectancy: | ||||||
For an individual aged 65 – male (years) | 86 | 86 | 85 | 86 | 87 | 85 |
For an individual aged 65 – female (years) | 88 | 88 | 87 | 89 | 89 | 87 |
Informa FSS | T&F GPS | UBMPS | UNEPS | |
Latest valuation date | 31.3.2020 | 30.9.2020 | 31.3.2020 | 5.4.2020 |
Funding (shortfall)/surplus at valuation date and agreed recovery plan amounts for UK Schemes | (£24.6m) | (£3.7m) | (£56.0m) | £3.8m |
£0.25m per | £2.5m per | |||
£2m per year | year to 30 | year to 30 | ||
to 30 June | September | September | ||
2026 | 2026 | 2025 | n/a |
Impact on Scheme liabilities: Increase amounts | |||||
Informa FSS | T&F GPS | UBMPS | UNEPS | Penton | |
Sensitivity analysis at 31 December 2023 | £m | £m | £m | £m | £m |
Discount rate – Decrease by 1.00% | 10.9 | 2.8 | 36.4 | 0.7 | 2.1 |
Rate of price inflation pre-retirement – Increase by 1.00% | 7.1 | 1.8 | 11.5 | 0.8 | n/a |
Life expectancy – Increase by 1 year | 2.0 | 0.5 | 13.3 | 1.5 | 0.5 |
2023 | 2022 | |
£m | £m | |
Recognised in profit before tax | ||
Past service credit and administrative expenses | 0.1 | 0.1 |
Interest (income)/cost on net pension surplus (Note 11) | (1.8) | 0.7 |
2023 | 2022 | |
£m | £m | |
Recognised in the Consolidated Statement of Comprehensive Income | ||
Actuarial loss on scheme assets | (2.3) | (188.7) |
Experience loss | (17.4) | (22.8) |
Change in irrecoverable element of pension surplus | 5.9 | (22.1) |
Change in demographic actuarial assumptions | 18.0 | 15.7 |
Change in financial actuarial assumptions | (16.0) | 244.8 |
Total recognised in the Consolidated Statement of Comprehensive Income | (11.8) | 26.9 |
2023 | 2022 | |
£m | £m | |
Movement in net surplus during the year | ||
Net surplus in Schemes at beginning of the year (before irrecoverable element of pension surplus) | 80.6 | 11.4 |
Past service credit and administrative expenses | (0.1) | (0.1) |
Net finance income/(cost) | 3.3 | (0.7) |
Actuarial (loss)/gain | (17.8) | 48.9 |
Deficit recovery contributions from the employer to the Schemes | 2.5 | 22.3 |
Effect of movement in foreign currencies | 0.4 | (1.2) |
Net surplus in Schemes at end of the year (before irrecoverable element of pension surplus) | 68.9 | 80.6 |
Irrecoverable element of pension surplus | (27.2) | (31.5) |
Net surplus in Schemes at end of the year after irrecoverable element of pension surplus | 41.7 | 49.1 |
2023 | 2022 | |
£m | £m | |
Present value of defined benefit obligations | (478.2) | (477.3) |
Fair value of Scheme assets | 547.1 | 557.9 |
Irrecoverable element of pension surplus | (27.2) | (31.5) |
Net surplus | 41.7 | 49.1 |
Reported as: | ||
Retirement benefit surplus recognised in the Consolidated Balance Sheet | 48.1 | 55.8 |
Deficit in scheme and liability recognised in the Consolidated Balance Sheet | (6.4) | (6.7) |
Net surplus | 41.7 | 49.1 |
2023 | 2022 | |
£m | £m | |
Opening present value of defined benefit obligation at 1 January | (477.3) | (735.2) |
Interest cost | (22.7) | (13.9) |
Benefits paid | 35.4 | 39.2 |
Actuarial (loss)/gain | (15.4) | 237.6 |
Effect of movement in foreign currencies | 1.8 | (5.0) |
Closing present value of defined benefit obligation at 31 December | (478.2) | (477.3) |
2023 | 2022 | |
£m | £m | |
Opening fair value of Scheme assets at 1 January | 557.9 | 746.6 |
Return on Scheme assets | 26.0 | 13.2 |
Actuarial loss | (2.4) | (188.7) |
Benefits paid | (35.4) | (39.2) |
Other payments from the Schemes | (0.1) | (0.1) |
Contributions from the employer to the Schemes | 2.5 | 22.3 |
Effect of movement in foreign currencies | (1.4) | 3.8 |
Closing fair value of Scheme assets at 31 December | 547.1 | 557.9 |
Informa FSS | T&F GPS | UBMPS | UNEPS | Penton | Total | |
31 December 2023 | £m | £m | £m | £m | £m | £m |
Equities | 9.9 | 2.3 | – | – | 7.9 | 20.1 |
Bonds and gilts | 23.1 | 5.4 | 107.2 | – | 12.2 | 147.9 |
Property | 9.0 | 2.2 | 62.1 | – | 2.5 | 75.8 |
Diversified growth fund | 9.9 | 2.3 | 41.1 | – | – | 53.3 |
Illiquid credit funds | 1.1 | 0.3 | 48.0 | – | – | 49.4 |
Bespoke funds (LDI and hedge funds) | 34.5 | 8.3 | 133.5 | – | 1.4 | 177.7 |
Annuity contracts | – | – | 3.8 | 11.9 | – | 15.7 |
Cash | 0.8 | 0.3 | 4.6 | 1.3 | 0.2 | 7.2 |
Total | 88.3 | 21.1 | 400.3 | 13.2 | 24.2 | 547.1 |
Informa FSS | T&F GPS | UBMPS | UNEPS | Penton | Total | |
31 December 2022 | £m | £m | £m | £m | £m | £m |
Equities | 15.1 | 3.8 | 43.6 | – | 8.4 | 70.9 |
Bonds and gilts | 7.2 | 1.6 | 72.4 | – | 11.0 | 92.2 |
Property | 8.9 | 2.1 | 66.1 | – | 5.0 | 82.1 |
Diversified growth fund | 15.6 | 3.9 | 59.2 | – | – | 78.7 |
Illiquid credit funds | 1.3 | 0.4 | 47.7 | – | – | 49.4 |
Bespoke funds (LDI and hedge funds) | 27.7 | 6.9 | 112.0 | – | 2.0 | 148.6 |
Annuity contracts | – | – | 4.3 | 12.6 | – | 16.9 |
Cash | 13.0 | 2.5 | 1.9 | 1.4 | 0.3 | 19.1 |
Total | 88.8 | 21.2 | 407.2 | 14.0 | 26.7 | 557.9 |
2023 | 2022 | ||
£m | £m | ||
Issued, authorised and fully paid | |||
1,368,029,699 | (2022: 1,418,525,746) ordinary shares of 0.1p each | 1.4 | 1.4 |
2023 | 2022 | |
Number of | Number of | |
shares | shares | |
At 1 January | 1,418,525,746 | 1,503,112,804 |
Issue of new shares to Employee Share Trust | – | 5,000,000 |
Issue of shares | 26,492,800 | – |
Share buyback | (76,988,847) | (89,587,058) |
At 31 December | 1,368,029,699 | 1,418,525,746 |
2023 | 2022 | |
£m | £m | |
At 1 January | 1,878.6 | 1,878.6 |
Issued in the year | – | – |
At 31 December | 1,878.6 | 1,878.6 |
Employee | |||||||
Share Trust | |||||||
Reserves for | and | Cash flow | Cost of | ||||
shares to be | Merger | Other | ShareMatch | hedging | hedging | ||
Issued | reserve | reserve | shares | reserve | reserve | Total | |
£m | £m | £m | £m | £m | £m | £m | |
At 1 January 2022 | 24.8 | 4,125.4 | (2,157.6) | (20.9) | 55.9 | 0.4 | 2,028.0 |
Share award expense (equity-settled) | 17.5 | – | – | – | – | – | 17.5 |
Shares for Trust purchase | (3.3) | – | – | – | – | – | (3.3) |
Transfer of vested LTIPs | (11.1) | – | – | – | – | – | (11.1) |
Fair value movements on derivatives in hedging relationships | – | – | – | – | (29.8) | 1.8 | (28.0) |
Share buyback (Note 30) | – | – | (74.9) | – | – | – | (74.9) |
At 31 December 2022 | 27.9 | 4,125.4 | (2,232.5) | (20.9) | 26.1 | 2.2 | 1,928.2 |
Share award expense (equity-settled) | 19.6 | – | – | – | – | – | 19.6 |
Shares for Trust purchase | (4.8) | – | – | – | – | – | (4.8) |
Transfer of vested LTIPs | (11.1) | – | – | – | – | – | (11.1) |
Fair value movements on derivatives in hedging relationships | – | – | – | – | 6.0 | (6.7) | (0.7) |
Issue of share capital | – | 173.7 | – | – | – | – | 173.7 |
Remeasurement of put call options | – | – | 1.5 | – | – | – | 1.5 |
Share buyback (Note 30) | – | – | (15.8) | – | – | – | (15.8) |
At 31 December 2023 | 31.6 | 4,299.1 | (2,246.8) | (20.9) | 32.1 | (4.5) | 2,090.6 |
Property | Other | ||
leases | leases | Total | |
£m | £m | £m | |
1 January 2022 | 83.4 | 115.9 | 199.3 |
Depreciation | (20.4) | (4.4) | (24.8) |
Additions | 17.0 | – | 17.0 |
Impairment reversal (Note 7) | 0.6 | – | 0.6 |
Disposals | (2.8) | – | (2.8) |
Foreign exchange movement | 4.8 | 13.9 | 18.7 |
1 January 2023 | 82.6 | 125.4 | 208.0 |
Depreciation | (21.9) | (4.4) | (26.3) |
Additions | 46.8 | – | 46.8 |
Impairment reversal (Note 7) | 0.6 | – | 0.6 |
Disposals | (6.9) | – | (6.9) |
Foreign exchange movement | (4.6) | (6.5) | (11.1) |
At 31 December 2023 | 96.6 | 114.5 | 211.1 |
Property | Other | ||
leases | leases | Total | |
£m | £m | £m | |
1 January 2022 | (143.6) | (122.3) | (265.9) |
Repayment of lease liabilities | 37.3 | 5.8 | 43.1 |
Interest on lease liabilities | (5.9) | (5.1) | (11.0) |
Additions | (17.0) | – | (17.0) |
Disposals | 3.3 | – | 3.3 |
Foreign exchange movement | (8.1) | (14.8) | (22.9) |
1 January 2023 | (134.0) | (136.4) | (270.4) |
Repayment of lease liabilities | 39.3 | 5.7 | 45.0 |
Interest on lease liabilities | (6.1) | (5.1) | (11.2) |
Additions | (46.8) | – | (46.8) |
Disposals | 3.8 | – | 3.8 |
Foreign exchange movement | 8.5 | 7.3 | 15.8 |
At 31 December 2023 | (135.3) | (128.5) | (263.8) |
2023 | |||
Current lease liabilities | (27.5) | (0.9) | (28.4) |
Non-current lease liabilities | (107.8) | (127.6) | (235.4) |
At 31 December 2023 | (135.3) | (128.5) | (263.8) |
2022 | |||
Current lease liabilities | (29.5) | (0.7) | (30.2) |
Non-current lease liabilities | (104.5) | (135.7) | (240.2) |
At 31 December 2022 | (134.0) | (136.4) | (270.4) |
Total | |
£m | |
2022 | |
Low value lease expense | – |
Short-term lease expense | (85.4) |
2023 | |
Low value lease expense | – |
Short-term lease expense | (152.9) |
Year ended | Year ended | |
31 December | 31 December | |
2023 | 2022 | |
£m | £m | |
Sales to joint ventures | (0.1) | (0.8) |
Sales to associates | (1.7) | – |
Purchases from associates | 2.2 | 2.4 |
Trade receivables owed by joint ventures | 0.1 | – |
Trade receivables owed by associates | 0.5 | – |
Trade payables owed to joint ventures | – | 0.2 |
Registered | |||
Company name | Country | Ownership | office |
Centre for Asia Pacific | Australia | 100.00% | AU1 |
Aviation Pty. Limited | |||
Centre for Aviation | Australia | 100.00% | AU1 |
Pty Limited | |||
Informa Holdings | Australia | 100.00% | AU1 |
(Australia) Pty Limited | |||
Datamonitor Pty Limited | Australia | 100.00% | AU2 |
Informa Australia | Australia | 100.00% | AU2 |
Pty Limtied | |||
Ovum Pty Limited | Australia | 100.00% | AU2 |
Curinos Australia | Australia | 56.24% | AU3 |
Pty Limited | |||
Arabian Exhibition | Bahrain | 100.00% | BA1 |
Management W.L.L. | |||
Informa Middle | Bermuda | 100.00% | BM1 |
East Limited | |||
Informa Markets Ltda | Brazil | 100.00% | BR1 |
AMB Tarsus Exhibitions | Cambodia | 100.00% | CB1 |
(Cambodia) Pte. Ltd. | |||
iNet Interactive | Canada | 100.00% | CA1 |
Canada Inc. | |||
Informa Canada Inc. | Canada | 100.00% | CA2 |
Informa Tech Canada Inc. Canada | 100.00% | CA2 | |
Curinos Inc. | Canada | 56.24% | CA3 |
Connect Biz Canada | Canada | 90.00% | CA4 |
Limited¹ | |||
Afterhurst (Beijing) | China | 100.00% | CH1 |
Information Consulting | |||
Co., Ltd. | |||
Canalys Economic | China | 100.00% | CH2 |
Information Consulting | |||
(Shanghai) Co., Ltd. | |||
China International | China | 70.00% | CH3 |
Exhibitions Co., Ltd. | |||
Foshan Huaxia | China | 65.00% | CH4 |
Home Textile | |||
Development Co., Ltd. | |||
Guangzhou CitiExpo | China | 60.00% | CH5 |
Jianke Exhibition Co., Ltd. | |||
Guangzhou Sinobake | China | 35.00% | CH6 |
International Exhibition | |||
Co., Ltd.³ | |||
IBC Conferences | China | 100.00% | CH7 |
and Event Management | |||
Services (Shanghai) | |||
Co., Ltd. | |||
Informa Baiwen | China | 59.50% | CH8 |
Exhibitions (Hangzhou) | |||
Co., Ltd. | |||
Informa Data Service | China | 100.00% | CH9 |
(Shanghai) Co., Ltd. | |||
Informa Enterprise | China | 100.00% | CH10 |
Management (Shanghai) | |||
Co., Ltd. | |||
Informa Exhibitions | China | 100.00% | CH11 |
(Beijing) Co., Ltd. | |||
Informa Information | China | 100.00% | CH12 |
Technology (Shanghai) | |||
Co., Ltd. | |||
Informa Markets China | China | 100.00% | CH13 |
(Chengdu) Co., Ltd. |
Registered | |||
Company name | Country | Ownership | office |
Informa Markets China | China | 100.00% | CH14 |
(Guangzhou) Co., Ltd. | |||
Informa Markets China | China | 100.00% | CH15 |
(Hangzhou) Co., Ltd. | |||
Informa Markets China | China | 100.00% | CH16 |
(Shanghai) Co., Ltd. | |||
Informa Markets China | China | 100.00% | CH17 |
(Shenzhen) Co., Ltd. | |||
Informa Tech (Shanghai) | China | 51.00% | CH18 |
Co., Ltd. | |||
Informa Tianyi | China | 60.00% | CH19 |
Exhibitions (Chengdu) | |||
Co., Ltd. | |||
Informa Weiner | China | 60.00% | CH20 |
Exhibitions (Chengdu) | |||
Co., Ltd. | |||
SCBE Exhibitions | China | 57.80% | CH21 |
(Shenzhen) Co., Ltd. | |||
Shanghai Baiwen | China | 85.00% | CH22 |
Exhibitions Co., Ltd. | |||
Shanghai IMsinoexpo | China | 70.00% | CH23 |
Digital Services Co., Ltd. | |||
Shanghai Informa | China | 70.00% | CH24 |
Markets ShowStar | |||
Exhibition Co., Ltd. | |||
Shanghai Meisheng | China | 85.00% | CH25 |
Culture Broadcasting | |||
Co., Ltd. | |||
Shanghai SinoExpo | China | 70.00% | CH26 |
Informa Markets | |||
International Exhibitions | |||
Co., Ltd. | |||
Shanghai Yingye | China | 60.00% | CH27 |
Exhibitions Co., Ltd. | |||
Shenzhen Bo Ao | China | 65.00% | CH28 |
Exhibition Co., Ltd. | |||
Shenzhen HKPCA Show | China | 51.00% | CH29 |
Co., Ltd. | |||
Shenzhen Informa | China | 65.00% | CH30 |
Markets Creativity | |||
Exhibition Co., Ltd. | |||
Shenzhen Shengshi | China | 75.00% | CH31 |
Jiuzhou Exhibition | |||
Co., Ltd. | |||
Shenzhen UBM Herong | China | 70.00% | CH32 |
Exhibition Co., Ltd. | |||
Shenzhen Zhongxincai | China | 70.00% | CH33 |
Exhibition Co., Ltd. | |||
Tarsus Exhibition | China | 100.00% | CH34 |
(Shanghai) Co., Ltd. | |||
Tarsus Exhibition | China | 100.00% | CH35 |
(Shenzhen) Co., Ltd. | |||
Tarsus Hope Exhibition | China | 100.00% | CH36 |
Co., Ltd. | |||
Zhengzhou Tarsus Hope | China | 100.00% | CH37 |
Exhibition Co., Ltd. | |||
Zhongshan Guzhen | China | 35.70% | CH38 |
Lighting Expo Co., Ltd¹ | |||
Stormcliff Limited | Cyprus | 100.00% | CY1 |
Informa Egypt LLC | Egypt | 100.00% | EG1 |
Euromedicom SAS | France | 100.00% | FR1 |
Eurovir SAS | France | 100.00% | FR1 |
Registered | ||||
Company name | Country | Ownership | office | |
New AG International | France | 100.00% | FR1 | |
S.à.r.l. | ||||
EBD Group GmbH | Germany | 100.00% | DE1 | |
Informa Holding | Germany | 100.00% | DE1 | |
Germany GmbH | ||||
Informa Tech | Germany | 100.00% | DE1 | |
Germany GmbH | ||||
UBM Canon Deutschland | Germany | 100.00% | DE1 | |
GmbH | ||||
Taylor & Francis | Germany | 100.00% | DE2 | |
Verlag GmbH | ||||
APLF Limited | Hong Kong | 60.00% | HK1 | |
Cosmoprof Asia Limited¹ | Hong Kong | 50.00% | HK1 | |
Great Tactic Limited | Hong Kong | 100.00% | HK1 | |
Hong Kong Sinoexpo | Hong Kong | 70.00% | HK1 | |
Informa Markets Limited | ||||
Informa Global Markets | Hong Kong | 100.00% | HK1 | |
(Hong Kong) Limited | ||||
Informa Limited | Hong Kong | 100.00% | HK1 | |
Informa Markets Asia | Hong Kong | 100.00% | HK1 | |
Group Limited | ||||
Informa Markets Asia | Hong Kong | 100.00% | HK1 | |
Holdings (HK) Limited | ||||
Informa Markets | Hong Kong | 100.00% | HK1 | |
Asia Limited | ||||
Informa Markets Asia | Hong Kong | 100.00% | HK1 | |
Partnership | ||||
Informa Markets South | Hong Kong | 100.00% | HK1 | |
China Limited | ||||
MAI Brokers | Hong Kong | 100.00% | HK1 | |
(Asia & Pacific) Limited | ||||
Mills & Allen Holdings | Hong Kong | 100.00% | HK1 | |
(Far East) Limited | ||||
Penton Media | Hong Kong | 100.00% | HK1 | |
Asia Limited | ||||
International Electronics | Hong Kong | 51.00% | HK2 | |
Circuit Exhibition | ||||
(Shenzhen) Company | ||||
Limited | ||||
Informa Markets India | India | 100.00% | IN1 | |
Private Limited | ||||
UBM Exhibitions India | India | 100.00% | IN1 | |
LLP | ||||
Taylor & Francis Books | India | 100.00% | IN2 | |
India Private Limited | ||||
Taylor & Francis | India | 100.00% | IN3 | |
Technology Services LLP | ||||
Canalys Solutions | India | 100.00% | IN4 | |
and Experiences | ||||
Private Limited | ||||
Tarsus Exhibitions India | India | 99.99% | IN5 | |
Private Limited | ||||
PT Pamerindo Indonesia | Indonesia | 100.00% | ID1 | |
PT Tarsus Indonesia SEA | Indonesia | 67.00% | ID3 | |
PT UBM Pameran | Indonesia | 67.00% | ID2 | |
Niaga Indonesia | ||||
Donytel Unlimited | Ireland | 100.00% | IR1 | |
Uncompany | ||||
F1000 | Open Science | Ireland | 100.00% | IR1 |
Platforms Limited |
Registered | |||
Company name | Country | Ownership | office |
Maypond Holdings | Ireland | 100.00% | IR1 |
Limited | |||
Maypond Limited | Ireland | 100.00% | IR1 |
Tanahol Unlimited | Ireland | 100.00% | IR1 |
Company | |||
Colwiz Limited | Ireland | 100.00% | IR2 |
UNM International | Isle of Man | 100.00% | IM1 |
Holdings Limited | |||
UNM Overseas Holdings | Isle of Man | 100.00% | IM1 |
Limited | |||
Informa Global Markets | Japan | 100.00% | JP1 |
(Japan) Co., Ltd | |||
Informa Intelligence | Japan | 100.00% | JP1 |
Godo Kaisha | |||
Informa Markets Japan | Japan | 100.00% | JP2 |
Co., Ltd | |||
Taylor & Francis | Japan | 100.00% | JP3 |
Japan Godo Kaisha | |||
Informa Jersey Limited | Jersey | 100.00% | JE1 |
Tarsus Group Limited | Jersey | 100.00% | JE2 |
UBM (Jersey) Limited | Jersey | 100.00% | JE2 |
UBM Limited | Jersey | 100.00% | JE2 |
CMP Holdings S.à.r.l. | Luxembourg | 100.00% | LX1 |
CMP Intermediate | Luxembourg | 100.00% | LX1 |
Holdings S.à.r.l. | |||
UBM Finance S.à r.l. | Luxembourg | 100.00% | LX1 |
UBM IP Luxembourg | Luxembourg | 100.00% | LX1 |
S.à.r.l. | |||
United Brazil Holdings | Luxembourg | 100.00% | LX1 |
S.à.r.l. | |||
United Commonwealth | Luxembourg | 100.00% | LX1 |
Holdings S.à.r.l. | |||
United CP Holdings | Luxembourg | 100.00% | LX1 |
S.à.r.l. | |||
United News Distribution | Luxembourg | 100.00% | LX1 |
S.à.r.l. | |||
United Professional | Luxembourg | 100.00% | LX1 |
Media S.à.r.l. | |||
UNM Holdings S.à.r.l. | Luxembourg | 100.00% | LX1 |
Vavasseur International | Luxembourg | 100.00% | LX1 |
Holdings S.à.r.l. | |||
Informa Markets | Malaysia | 100.00% | MA1 |
Malaysia Sdn Bhd | |||
Malaysian Exhibition | Malaysia | 100.00% | MA1 |
Services Sdn Bhd | |||
UBM Tech Research | Malaysia | 100.00% | MA1 |
Malaysia Sdn Bhd | |||
UBMMG Holdings | Malaysia | 100.00% | MA1 |
Sdn Bhd | |||
AMB Tarsus Exhibitions | Malaysia | 100.00% | MA2 |
Sdn Bhd | |||
UBM Mexico | Mexico | 100.00% | ME1 |
Exposiciones, S.A.P.I. | |||
Tarsus Services, S. de R.L. de C.V. | Mexico | 100.00% | ME2 |
Informa Monaco SAM | Monaco | 100.00% | MC1 |
Monaco Yacht Show SAM | Monaco | 90.00% | MC1 |
Myanmar Trade Fair | Myanmar | 100.00% | MY1 |
Management | |||
Company Limited |
Registered | |||
Company name | Country | Ownership | office |
AMB Tarsus Exhibitions | Myanmar | 100.00% | MY2 |
(Myanmar) Pte. Ltd. | |||
IIR South Africa B.V. | Netherlands | 100.00% | NL1 |
Informa Europe B.V. | Netherlands | 100.00% | NL1 |
Informa Finance B.V. | Netherlands | 100.00% | NL1 |
Informa Markets B.V. | Netherlands | 100.00% | NL1 |
UBM Asia B.V. | Netherlands | 100.00% | NL2 |
Dove Medical Press (NZ) | New Zealand | 100.00% | NZ1 |
Limited | |||
Informa Healthcare A.S. | Norway | 100.00% | NO1 |
Colwiz Pakistan | Pakistan | 99.98% | PK1 |
Private Limited | |||
UBM Exhibitions | Philippines | 100.00% | PH1 |
Philippines Inc | |||
AMB Tarsus Exhibitions | Philippines | 100.00% | PH2 |
(Philippines) Corporation | |||
PEP Tarsus Corporation | Philippines | 51.00% | PH3 |
Informa and Tharawat | Qatar | 49.00% | QA1 |
Limited¹ | |||
Informa Markets BN | Republic of | 60.00% | RK1 |
Co Ltd. | Korea | ||
Informa Markets Korea | Republic of | 100.00% | RK1 |
Corporation | Korea | ||
Informa Tech Korea | Republic of | 100.00% | RK2 |
Co., Ltd. | Korea | ||
Tahaluf Events Limited | Saudi Arabia | 51.00% | SU1 |
Informa Saudi Arabia | Saudi Arabia | 100.00% | SU2 |
LLC² | |||
IBC Asia (S) Pte Ltd. | Singapore | 100.00% | SG1 |
Taylor & Francis (S) | Singapore | 100.00% | SG1 |
Pte Ltd | |||
Informa Global Markets | Singapore | 100.00% | SG1 |
(Singapore) Pte Limited | |||
Informa Exhibitions | Singapore | 100.00% | SG2 |
Pte Limited | |||
Sea Asia Singapore Pte | Singapore | 90.00% | SG2 |
Limited | |||
Singapore Exhibition | Singapore | 100.00% | SG2 |
Services (Pte) Limited | |||
Tarsus (Singapore) | Singapore | 100.00% | SG3 |
Pte Ltd | |||
Canalys Pte. Ltd. | Singapore | 100.00% | SG4 |
Marketworks | South Africa | 100.00% | SA1 |
Datamonitor (Pty) Ltd | |||
Institute for International | Spain | 100.00% | SP1 |
Research Espana S.L. | |||
Co-Action Publishing AB | Sweden | 100.00% | SE1 |
Taylor & Francis AB | Sweden | 100.00% | SE1 |
Informa IP GmbH | Switzerland | 100.00% | SW1 |
Informa Tech Taiwan | Taiwan | 100.00% | TA1 |
Limited | |||
Bangkok Exhibition | Thailand | 100.00% | TH1 |
Services Ltd. | |||
UBM Asia (Thailand) | Thailand | 49.00% | TH1 |
Co. Ltd³ | |||
UBM Istanbul Fuarcılık | Turkey | 100.00% | TU1 |
ve Gösteri Hizmetleri A.Ş. | |||
Sada Uzmanlik | Turkey | 60.00% | TU2 |
Fuarlari A.S |
Registered | ||||
Company name | Country | Ownership | office | |
Tarsus Turkey Fuarcılık | Turkey | 100.00% | TU3 | |
Anonim Şirketi | ||||
ABI Building Data | UK | 100.00% | UK1 | |
Limited | ||||
Afterhurst Limited | UK | 100.00% | UK1 | |
Blessmyth Limited | UK | 100.00% | UK1 | |
Canrak Books Limited | UK | 100.00% | UK1 | |
CapRegen BioSciences | UK | 100.00% | UK1 | |
Limited | ||||
CapRegen Limited | UK | 100.00% | UK1 | |
CapRegen Magnum | UK | 100.00% | UK1 | |
Limited | ||||
CapRegen Natural | UK | 100.00% | UK1 | |
BioSciences Limited | ||||
CapRegen Nutraceuticals | UK | 100.00% | UK1 | |
Limited | ||||
Colonygrove Limited | UK | 100.00% | UK1 | |
Colwiz UK Limited | UK | 100.00% | UK1 | |
Crosswall Nominees | UK | 100.00% | UK1 | |
Limited | ||||
Curinos International | UK | 56.24% | UK1 | |
Limited | ||||
Curinos Limited | UK | 56.24% | UK1 | |
Datamonitor Limited | UK | 100.00% | UK1 | |
Design Junction Limited | UK | 100.00% | UK1 | |
DIVX Express Limited | UK | 100.00% | UK1 | |
Dove Medical Press | UK | 100.00% | UK1 | |
Limited | ||||
Expert Publishing | UK | 100.00% | UK1 | |
Medicine Ltd. | ||||
Expert Publishing | UK | 100.00% | UK1 | |
Science Ltd. | ||||
F1000 | Research Limited | UK | 100.00% | UK1 |
Fairs & Exhibitions (1992) | UK | 100.00% | UK1 | |
Limited | ||||
Fairs And Exhibitions | UK | 100.00% | UK1 | |
Limited | ||||
Futurum Media Limited | UK | 100.00% | UK1 | |
GNC Media Investments | UK | 100.00% | UK1 | |
Limited | ||||
Green Thinking (Services) | UK | 100.00% | UK1 | |
Limited | ||||
Hirecorp Limited | UK | 100.00% | UK1 | |
IBC (Ten) Limited | UK | 100.00% | UK1 | |
IBC (Twelve) Limited | UK | 100.00% | UK1 | |
IIR (UK Holdings) | UK | 100.00% | UK1 | |
Limited | ||||
IIR Management Limited | UK | 100.00% | UK1 | |
Industry Dive, Ltd. | UK | 100.00% | UK1 | |
Informa Connect | UK | 100.00% | UK1 | |
Limited | ||||
Informa Cosec Limited | UK | 100.00% | UK1 | |
Informa Exhibitions | UK | 100.00% | UK1 | |
Limited | ||||
Informa Final Salary | UK | 100.00% | UK1 | |
Pension Trustee Company | ||||
Limited | ||||
Informa Finance Australia | UK | 100.00% | UK1 | |
Limited |
Registered | |||
Company name | Country | Ownership | office |
Informa Finance Brazil | UK | 100.00% | UK1 |
Limited | |||
Informa Finance Egypt | UK | 100.00% | UK1 |
Limited | |||
Informa Finance Mexico | UK | 100.00% | UK1 |
Limited | |||
Informa Finance USA | UK | 100.00% | UK1 |
Limited | |||
Informa Global Markets | UK | 100.00% | UK1 |
(Europe) Limited | |||
Informa Group Holdings | UK | 100.00% | UK1 |
Limited | |||
Informa Group Limited | UK | 100.00% | UK1 |
Informa Holdings | UK | 100.00% | UK1 |
Limited | |||
Informa Investment Plan | UK | 100.00% | UK1 |
Trustees Limited | |||
Informa Investments | UK | 100.00% | UK1 |
Limited | |||
Informa Manufacturing | UK | 100.00% | UK1 |
Europe Holdings | |||
Limited | |||
Informa Manufacturing | UK | 100.00% | UK1 |
Europe Limited | |||
Informa Markets | UK | 100.00% | UK1 |
(Europe) Limited | |||
Informa Markets | UK | 100.00% | UK1 |
(Maritime) Limited | |||
Informa Markets (UK) | UK | 100.00% | UK1 |
Limited | |||
Informa Markets | UK | 100.00% | UK1 |
Limited | |||
Informa Overseas | UK | 100.00% | UK1 |
Investments Limited | |||
Informa Property | UK | 100.00% | UK1 |
(Colchester) Limited | |||
Informa Six Limited | UK | 100.00% | UK1 |
Informa Tech Founders | UK | 55.00% | UK1 |
Limited | |||
Informa Tech Research | UK | 100.00% | UK1 |
Limited | |||
Informa Telecoms & | UK | 100.00% | UK1 |
Media Limited | |||
Informa Three Limited | UK | 100.00% | UK1 |
Informa UK Limited | UK | 100.00% | UK1 |
Informa United Finance | UK | 100.00% | UK1 |
Limited | |||
Informa US Holdings | UK | 100.00% | UK1 |
Limited | |||
ITF2 Limited | UK | 55.00% | UK1 |
Light Reading UK Limited | UK | 100.00% | UK1 |
London On-Water Ltd | UK | 100.00% | UK1 |
LSX Limited | UK | 100.00% | UK1 |
MAI Luxembourg UK | UK | 100.00% | UK1 |
Societas | |||
Miller Freeman | |||
Worldwide Limited |
Registered | |||
Company name | Country | Ownership | office |
Tiger Acquisitions UK | UK | 100.00% | UK1 |
Limited | |||
TU-Automotive | UK | 100.00% | UK1 |
Holdings Limited | |||
TU-Automotive Limited | UK | 100.00% | UK1 |
Turtle Diary Limited | UK | 100.00% | UK1 |
UBM (GP) No1 Limited | UK | 100.00% | UK1 |
UBM Aviation Worldwide | UK | 100.00% | UK1 |
Limited | |||
UBM International | UK | 100.00% | UK1 |
Holdings UK Societas | |||
UBM Property Services | UK | 100.00% | UK1 |
Limited | |||
UBM Shared Services | UK | 100.00% | UK1 |
Limited | |||
UBM Trustees Limited | UK | 100.00% | UK1 |
UBMG Holdings | UK | 100.00% | UK1 |
UBMG Services Limited | UK | 100.00% | UK1 |
United Consumer Media | UK | 100.00% | UK1 |
UK Societas | |||
United Executive | UK | 100.00% | UK1 |
Trustees Limited | |||
United Newspapers | UK | 100.00% | UK1 |
Publications Limited | |||
United Trustees Limited | UK | 100.00% | UK1 |
UNM Investments | UK | 100.00% | UK1 |
Limited | |||
Vavasseur Overseas | UK | 100.00% | UK1 |
Holdings Limited | |||
Canalys.com Ltd. | UK | 100.00% | UK2 |
Smarter Shows (Tarsus) | UK | 100.00% | UK3 |
Limited | |||
Smarter Shows (No 2) | UK | 100.00% | UK3 |
Limited | |||
Times Aerospace | UK | 51.00% | UK4 |
Publishing Limited | |||
Times Aerospace | UK | 51.00% | UK4 |
Publishing Holdings | |||
Limited | |||
Informa Middle East | United Arab | 100.00% | UAE1 |
Media FZ LLC | Emirates | ||
F&E LLC FZE | United Arab | 100.00% | UAE2 |
Emirates | |||
Curinos LLC | USA | 56.24% | US1 |
FBX Novantas | USA | 56.24% | US1 |
Holdings Inc. | |||
Curinos, Inc. | USA | 56.24% | US1 |
Farm Progress Limited | USA | 100.00% | US1 |
Ibis JV, LP | USA | 56.24% | US1 |
Informa Business | USA | 100.00% | US1 |
Media Holdings, Inc. | |||
Informa Business | USA | 100.00% | US1 |
Media, Inc. | |||
Informa Data | USA | 100.00% | US1 |
Sources, Inc. | |||
Informa Exhibitions | USA | 100.00% | US1 |
Holding Corp. | |||
Informa Exhibitions | USA | 100.00% | US1 |
U.S. Construction & Real | |||
Estate, Inc. |
Registered | |||
Company name | Country | Ownership | office |
Informa Exhibitions, LLC | USA | 100.00% | US1 |
Informa Global Sales, Inc. | USA | 100.00% | US1 |
Informa Global Shared | USA | 100.00% | US1 |
Services LLC | |||
Informa Ibis GP, LLC | USA | 100.00% | US1 |
Informa Ibis Holdings | USA | 56.24% | US1 |
Inc. | |||
Informa Ibis Inc. | USA | 56.24% | US1 |
Informa Intrepid | USA | 100.00% | US1 |
Holdings Inc. | |||
Informa Life Sciences | USA | 100.00% | US1 |
Exhibitions, Inc. | |||
Informa Markets Fashion | USA | 100.00% | US1 |
(East) LLC | |||
Informa Markets | USA | 100.00% | US1 |
France, Inc. | |||
Informa Markets | USA | 100.00% | US1 |
Holdings, Inc. | |||
Informa Markets | USA | 100.00% | US1 |
Investments, Inc | |||
Informa Markets | USA | 100.00% | US1 |
Manufacturing LLC | |||
Informa Media, Inc. | USA | 100.00% | US1 |
Informa Operating | USA | 100.00% | US1 |
Holdings, Inc. | |||
Informa Tech Holdings | USA | 100.00% | US1 |
LLC | |||
Informa Markets | USA | 100.00% | US1 |
Medica LLC | |||
Informa Tech LLC | USA | 100.00% | US1 |
Informa US Beauty | USA | 100.00% | US1 |
Holdings LLC | |||
Internet World Media, Inc. | USA | 100.00% | US1 |
LOE Holdings, LLC | USA | 100.00% | US1 |
Ludgate USA LLC | USA | 100.00% | US1 |
Piattaforma LLC | USA | 60.00% | US1 |
Roast LLC | USA | 100.00% | US1 |
Spectrum ABM Corp. | USA | 100.00% | US1 |
UBM Delaware LLC | USA | 100.00% | US1 |
UBM Finance, Inc. | USA | 100.00% | US1 |
UBM UK LLC | USA | 100.00% | US1 |
USA Beauty LLC¹ | USA | 45.00% | US1 |
Winsight, LLC | USA | 100.00% | US1 |
Taylor & Francis | USA | 100.00% | US1 |
Group, LLC | |||
Technomic, Inc. | USA | 100.00% | US1 |
Brainweek, LLC | USA | 100.00% | US2 |
Canalys.com, Inc. | USA | 100.00% | US2 |
Caroo Development Inc. | USA | 100.00% | US2 |
Caroo USA Inc. | USA | 100.00% | US2 |
Connect Biz, LLC³ | USA | 90.00% | US2 |
Connect Travel, LLC | USA | 100.00% | US2 |
Foundermade LLC | USA | 65.00% | US2 |
Montana Street | USA | 100.00% | US2 |
Consultants, Inc. | |||
Natural Biosciences Inc. | USA | 100.00% | US2 |
Registered | |||
Company name | Country | Ownership | office |
Tarsus Partners, L.P. | USA | 100.00% | US2 |
Scuba Holdings, Inc. | USA | 100.00% | US2 |
Tarsus Atlantic | USA | 100.00% | US2 |
Holdings LLC | |||
Industry Dive, Inc. | USA | 100.00% | US2 |
Tarsus Bodysite LLC | USA | 60.00% | US2 |
MCI OPCO, LLC | USA | 100.00% | US2 |
Tarsus Events, LLC | USA | 100.00% | US2 |
Tarsus Exhibitions, LLC | USA | 100.00% | US2 |
Tarsus Mexico Events, LLC | USA | 100.00% | US2 |
Tarsus GEP, Inc. | USA | 100.00% | US2 |
Tarsus Map LLC | USA | 70.00% | US2 |
Tarsus US Holdings | USA | 100.00% | US2 |
Incorporated | |||
Trade Show News | USA | 100.00% | US3 |
Network, Inc. | |||
UBM Community | USA | 100.00% | US4 |
Connection Foundation | |||
Netline Corporation | USA | 100.00% | US5 |
Duke Investments, Inc. | USA | 100.00% | US6 |
Informa Markets Art, LLC | USA | 90.00% | US7 |
Informa Support | USA | 100.00% | US7 |
Services, Inc. | |||
Informa Marine | USA | 90.00% | US7 |
Holdings, Inc. | |||
Fort Lauderdale | USA | 90.00% | US7 |
Convention Services, Inc. | |||
Yachting Promotions, Inc. | USA | 90.00% | US7 |
Southern Convention | USA | 90.00% | US7 |
Services. Inc. |
Registered | |||
Company name | Country | Ownership | office |
Advanstar | USA | 100.00% | US8 |
Communications, Inc. | |||
Informa Princeton LLC | USA | 100.00% | US8 |
CMP Child Care | USA | 100.00% | US8 |
Center, Inc | |||
Knect365 US, Inc. | USA | 100.00% | US8 |
Informa Business | USA | 100.00% | US9 |
Intelligence, Inc. | |||
Informa USA, Inc. | USA | 100.00% | US9 |
Ovum, Inc. | USA | 100.00% | US9 |
Metabolic Medical | USA | 100.00% | US10 |
Institute, Inc. | |||
Tarsus Advon | USA | 100.00% | US10 |
Holdings, Inc. | |||
Tarsus Cardio, Inc. | USA | 100.00% | US10 |
Tarsus Medical | USA | 100.00% | US10 |
Education LLC | |||
Tarsus Direct LLC | USA | 100.00% | US10 |
Medical Conferences | USA | 100.00% | US11 |
International, Inc. | |||
DMS Group, LLC | USA | 100.00% | US12 |
Off-Price Specialists | USA | 100.00% | US13 |
Center | |||
Evolve OP, LLC | USA | 85.00% | US14 |
GKT Events LLC | USA | 75.00% | US15 |
Tarsus Expositions, Inc. | USA | 100.00% | US16 |
Tarsus Publishing, Inc. | USA | 100.00% | US17 |
Tarsus Connect, LLC | USA | 100.00% | US18 |
Health Connect | USA | 60.00% | US19 |
Partners Inc. | |||
SES Vietnam Exhibition | Vietnam | 100.00% | VE1 |
Services Company | |||
Limited |
Registered | ||||
office | Registered office address | |||
AU1 | c/o LBW & Partners, Level 3, 845 Pacific Highway, | |||
Chatswood, NSW 2067, Australia | ||||
AU2 | Level 4, 24 York Street, Sydney, NSW 2000, Australia | |||
AU3 | c/o Kelly Partners (Northern Beaches) Pty Ltd, Unit 15, | |||
117 Old | Pittwater Road, Brookvale NSW 2100, Australia | |||
BA1 | Building 1, Road 22, Block 414, Al-Daih, PO Box 20200, | |||
Jidhafs, Bahrain | ||||
BM1 | Victoria Place, 5th Floor, 31 Victoria Street, Hamilton, | |||
HM10, Bermuda | ||||
BR1 | Avenida Doutora Ruth Cardoso, 7221, 22/C2301/B.A, | |||
Pinheiros, São Paulo – SP, CEP 05425-902, Brazil | ||||
CA1 | c/o McMillan LLP, 1500 Royal Centre, 1055 W. Georgia | |||
Street, Vancouver, BC V6E 4N7, Canada | ||||
CA2 | 12th Floor, 20 Eglinton Avenue West, Yonge Eglinton | |||
Centre, Toronto, ON M4R 1K8, Canada | ||||
CA3 | 181 | University Avenue, Suite 1100, Toronto, ON M5H 3M7, | ||
Canada | ||||
CA4 | PO Box 49130, | 2900-595 Burrard Street, Vancouver BC BC | ||
V7X 1J5, Canada | ||||
CB1 | Building #128, Office No. 103, 1st Floor, Russian Federation | Bvld (110), Sangkat Toek Laak 1, Khan Tuol Kork, Phnom | ||
Penh, Cambodia | ||||
CH1 | Unit 101, 1st Floor, Building 8, Yard 1, Gaolizhang Road, | |||
Haidian District, Beijing, China | ||||
CH2 | Room 310, Building 2, No. 98 Yan Ping Road, Jing An | |||
District, Shanghai, China | ||||
CH3 | Floor 7/8, Urban Development International Tower, | |||
No. 355 | Hong Qiao Road, Xu Hui District, | |||
Shanghai, 200030, | China | |||
CH4 | Room 2602, | Financial Centre, 28 Haiwu Road, Guicheng Street, Nanhai | Building 1, South China International | |
District, Foshan, China | ||||
CH5 | Room 902, No. 996 East Xingang Road, Haizhu District, | |||
Guangzhou, China | ||||
CH6 | Room 2807, | East Xingang Road, Haizhu District, | No. 1022 | |
Guangzhou, China | ||||
CH7 | Room 2072, | 2nd Floor, 124 Building, No. 960 Zhong Xing | ||
Road, Jing'an District, Shanghai, China | ||||
CH8 | Room 537, No.857 of North Shixin Road, Xiaoshan District, | |||
Hangzhou, China | ||||
CH9 | Room 6396 | No. 650 | Dingxi Road, Changning District, | |
Shanghai, China | ||||
CH10 | Room 2201 | Hong Kong New Tower, No. 300 Huai Hai | ||
Middle Road, Huang Pu District, Shanghai, China | ||||
CH11 | Unit 802 Comfort Plaza, No. 4 of Worker's Stadium North | |||
Road, Chaoyang District, Beijing 100027, China | ||||
CH12 | West-South Area Fl. 3, No. 2123 Pudong Avenue, | |||
Free Trade Zone, Shanghai, China | ||||
CH13 | Ningbo Road, Zhengxing Street, Tianfu New District, | China (Sichuan) Pilot Free Trade Zone, East Section of | ||
Chengdu, China | ||||
CH14 | Room 1159-1164, China Hotel Office Tower, Liu Hua Road, | |||
Guangzhou, China | ||||
CH15 | Room 123, Floor 1, Building 1, No.108 Kangqiao Road, | |||
Gongshu District, Hangzhou, China | ||||
CH16 | Room 207, No. 453 Fahuazhen Road, Shanghai, China | |||
CH17 | V3 East, Level 17 Daqing Building, Tian'an Shatou Street, | |||
Futian District, Shenzhen, China | ||||
CH18 | Room 501-7, 1566 West Yan’an Road, Changning District, | |||
Shanghai, China |
Registered | ||
office | Registered office address | |
CH19 | No 502, 5th Floor, Building 4, 99 Guangfu Road, Wuhou | |
District, Chengdu, China | ||
CH20 | Room 1009, | Western Tower No. 19, Way 4, South People |
Road, Chengdu City, China | ||
CH21 | 8C-28E, Xinlikang Building, 3044 Xinghai Avenue, Nanshan | Street, Qianhai Shenzhen-Hong Kong Cooperation Zone, |
Shenzhen 518966, China | ||
CH22 | Room 1010, | 10F, No. 993 West Nanjing Road, Jingan |
District, Shanghai, China | ||
CH23 | 8/F UDIT, 355 Hong Qiao Road, Shanghai 200030, China | |
CH24 | Unit 2901, | K11 Atelier, 300 Huai Hai Road Central, |
Huangpu District, Shanghai 200021, China | ||
CH25 | Room 101‑75, No.15 Jia, No. 152 Alley, Yanchang Road, | |
Jing'an District, Shanghai, China | ||
CH26 | Room 608, Block A, No. 1 Building, No. 3000 Longdong | |
Avenue, Pilot Free Trade Zone, Shanghai, China | ||
CH27 | Room 234, 2nd Floor, M-Zone, 1st Building, No 3398 Hu | |
Qing Ping Road, Zhao Xiang Town, Qing Pu District, | ||
Shanghai, China | ||
CH28 | Room 1405S, 14th Floor, Times Financial Center, No. 4001 | |
Shennan Avenue, Fu'an Community, Futian Street, Futian | ||
District, Shenzhen, China | ||
CH29 | Unit 2607B, 26/F, Huarong Building, 178 Mintian Road, | |
Futian District, Shenzhen, China | ||
CH30 | L28-02, Building No. 3, Zuoyue Financial Centre, No. 5033 | |
of Menghai Avenue, Shenzhen, China | ||
CH31 | Room 1703, | Block C, Tairan Building, Futian District, |
Shenzhen, China | ||
CH32 | Room 607, East Block, Coastal Building, Haide 3rd Road, | |
Nanshan District, Shenzhen, Guangdong 518054, China | ||
CH33 | Room 1303, | Building 3, Zhongkang Road 128, Meilin |
Community, Meilin Street, Futian District, Shenzhen, China | ||
CH34 | Room V1134, 11F, No. 158 Shuanglian Road Qingpu | |
District, Shanghai, China | ||
CH35 | 44AC-1229, Block A, NEO Lvjing Era Building, 6011 | |
Shennan Avenue, Futian District, Shenzhen, China | ||
CH36 | Rm D326, No. 1 – 9 Clapping Hands Incubator, Tower A, Asia | Trade Plaza, No. 628 Wuluo Road, Zhongnan Road Street, |
Wuchang District, Wuhan City, Hubei Province, China | ||
CH37 | Rm. 2106, | No.60, Zi Jinshan Road, Cheng District, |
Zhengzhou, China | ||
CH38 | 2F, Guzhen Convention & Exhibition Center, | |
Zhongshan, Guangdong, China | ||
CY1 | 2nd Floor, Sotiri Tofini 4, Agios Athanasios, | |
Limassol, 4102, Cyprus | ||
DE1 | Kaufingerstraße 24, 80331 Munich, Germany | |
DE2 | Knesebeckstraße 62/63, 10719 Berlin, Germany | |
EG1 | 7H Building, Street 263, New Maadj, Cairo, Egypt | |
FR1 | 37 avenue de Friedland, 75008, Paris, France | |
HK1 | Room 812, Silvercord, Tower 1, 30 Canton Road, | |
Tsimshatsui, Kowloon, Hong Kong | ||
HK2 | Unit 1508, | 15/F., Greenfield Tower, No. 1 Science |
Museum Road, Tsimshatsui, Hong Kong | ||
ID1 | Menara Jamsostek Utara, Lanatai 12 Unit 12‑04, Jalan | |
Jendral Gatot Subroto No. 38, Jakarta 12710, Indonesia | ||
ID2 | Intiland Tower, 19th Floor, Jalan Jendral Sudirman No.32, | |
Jakarta Pusat, 10220, Indonesia | ||
IM1 | First Names House, Victoria Road, Douglas, Isle of Man, | |
IM2 4DF, Isle of Man |
WI 53226 |
Registered | |
office | Registered office address |
US11 | c/o CT Corporation System, 208 S. Lasalle Street, Suite 814, |
Chicago, IL 60604, USA | |
US12 | c/o CT Corporation System, 6300 N. River Road, Suite 300, |
Rosemont, IL 60018, USA | |
US13 | c/o CT Corporation System, 701 S. Carson Street, Suite 200, |
Carson City, NV 89701, USA | |
US14 | c/o CT Corporation System, 301 S. Bedford Street, Suite 1, |
Madison, WI 53703, USA | |
US15 | c/o Denasha A. Scott, 1200 N. Mayfair Road, Suite 430, |
Milwaukee, WI 53226, USA |
Registered | |
office | Registered office address |
US16 | c/o CT Corporation System, 4400 Easton Commons Way, |
Suite 125, Columbus, OH 43219 | |
US17 | c/o CT Corporation System, 2 Office Park Court, Suite 103, |
Columbia, SC 29233, USA | |
US18 | c/o Northwest Agent Registered Services Inc., 300 Colonial |
Center Parkway, Suite 100N, Roswell, GA 30076, USA | |
US19 | 65 Business Park Drive, Lebanon, TN 37090, USA |
VE1 | 10th Floor., Ha Phan Building, 17-17A-19, Ton That Tung |
Street, District 1, HCMC, Vietnam |